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Abstract
Spider silk is one of nature's most promising biomaterial s for a variety of applications, however, due to
the inability to fann spiders , transgenic hosts are required for large-scale production . With the unique
combination of strength, elasticity , and biocompatibility, sp ider s ilk has an incredible potential for use in
the human body. This study was conducted to merge two major applications of spider s ilk for the creation
of a novel bandaging product. Electrospinning technology was utiliz ed to create a spide r silk/polym er
bandage matrix to be applied with an aqueous spider silk skin adhesive.

In designing the bandaging matrix , the mechanical properties of the electrospun si lk were evaluated
against commercially-available

product s and known values of human skin. The chosen formulation had

phys ica l properties more comparable human skin than commercially-available products. The aqueous
adhesive was tested in conjunction with the electro spun matrix for its adhesion and found comparable to
commercial product s. The durability of the bandage was tested via cyclic stresses and found analogous to
commercial products. The common antimicrobial chlorhexidine was incorporated into the adhesive and
had a release profile lasting about 4 day s. With this incorporation into the aqueous adhesive, the adhesive
can be reapplied to provide additional antimicrobial protection, a necessity in the healthcare industry. The
bandaging showed no signs of inhibiting mammalian cell proliferati on under cytotoxicity testing.
The final product, deemed " SpiderSkin," presents a unique bandaging solution capable of providing a
healthy environment for the regeneration of epidermal tissue, while protecting the wound from outside
infection , and providing mechanical stabi lity similar to that of human ski n.
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Project Summary
The purpo se of this project was to create a bandaging produ ct by harnessing the mechanical prop ert ies of
recombinant spider silk protein s (rSSps). Using an electrospinning device , the goal was to create an
rSSps /polymer bandage matrix made of nanofiber s that can be incorporated with an aqueous rSSps skin
adhesive to create an ultra-thin "secon d skin" to act as a barrier of defense in the event of a skin injury .
Furthermore , thi s bandage may promot e healing by the elution of antimicrobials, growth factors, and
other healing agents, while takin g advantage of the biocompatibility of the rSSps. This product will be
mechanically sound under varied mechanical manipulation as well as under different environmental
conditions. The resulting electrospun bandage matrix and adhesive will allow for an innovative product to
both protect and heal numerous skin injurie s and will reduce the need for hospital staff to constantly
change dress ings (a painful proce ss) since the components of this product will eventually degrade over
time or simply peel off. Finally, the design of this product will provide a starting point for numerou s
future projects including the possi bility for a mechanically-stable cell scaffold to regenerate a patient 's
skin in the event of major injury . The final product was named " SpiderSkin".

Introduction
The human body 's fir st layer of protection against the elements, disease, and regulation of internal
processes is the skin. To provide effective protection , the skin must be able to regenerate as quickly as it
is damaged. Unfortunately, in cases of extreme injuries, such as burns or large abrasions, or cases of
decreased blood flow, as in pressure wounds, natural repair mechani sms prove insufficient. These injuries
are both widespread and costly. The American Bum association estimates over 486,000 burn injurie s
were treated in US burn centers in 2015 ("American Burn Association," n.d.). Approximately 2.5 million
people are affected by pressure sores each year of which 159,000 are nursing home resident s ("American
Burn Association").

In the above circumstances where extensive damage to the skin occurs, an extra layer of defense ,
effectively a second layer of skin, is needed to maintain the health and wellness of affected individuals.
This "seco nd skin" must have similar prope1ties to that of the original: permeability , flexibility, and
protection aga inst infection. The product may also serve as a scaffold for re-epithelialization.
The purpo se of thi s study was to develop a seco nd skin ca pable of providing the environment nece ssary
for natural repair while protecting the skin from further damage. The product was evaluated through
te sting of mechanical prope1ties and cellular interaction s.

Significance and Innovation
Bandages protect wounds and promote healing by creating a moist environment that allows for natural
repair without significant disruption. Problem s in the wound care industry today are numerous , and there
have been many effo1ts to combat the se . The main problem s that this study sought to solve are: the
occurrence of skin maceration and contact dermatitis in the skin surrounding the wound (made worse by
continual dress ing changes), the ability to tune a banda ge as the wound environment and needs change,
1

and com batting the risk of infection in immun ocompromi sed patients. The goal of this project was to
create a bandaging proce ss that will decrease the healing time and sca rring of wounds like bed sores or
burn s, without increa sing the damage to the skin during dressing changes and wound treatment.

Objectives
The main objective of this project is to create an rSSps electrospun "seco nd skin" with an rSSps-based
adhesive that has the ability to match or surpass the properties of skin, while being comparable to the
mechanical prope11ies of commercial product s. Fu11hermore, this product will promote hea ling through
the elution of antimicrobials. The following are specific objectives related to the electrospun mat ,
adhesive, and the mat adhesive complex:
•

Use glutaraldehyde as a cross-linking agent to increa se the mechanical properties of the adhesive.

•

Ens ure that the bandage (with and without glutaraldehyde) does not exhibit cytotoxicity.

•

Create a mat/adhesive complex with and without cross-linking that stretc hes without removal in
cyclic flexion on pigskin.

•

Create a mat/adhesive complex with and without cross-linking that can be manipulat ed without
removal in cyclic compression on pigskin.

•

Create an rSSps antimicrobial adhesive using chlorhexidine and exhibit a release of the drug over
time.

•

Design a mat/adhesive complex that adheres to the skin as well as or better than commercial skin
adhesives.

Evaluation Criteria
This project will be evaluated based on the following criteria:
•

Test different electrospun mat formulations using different concentrations and combinations of
rSSps. Test the workability of these mat combinations by evaluating spinning effectiveness,
material availability, and a pressu re-sensitive tape test.

•

Evaluate rSSps adhesives with and without cross-linking by including these two groups in eve1y
mechanical adhesion test as well as an MTS tensile test for each complex.

•

Perform SEM imaging to observe the interaction between mat/adhesive to form a complex.

•

Perform cytotoxicity testing using both sets of adhesives (with and without glutaraldehyde).

•

Complete cyclic MTS fatigue testing with the banda ges inflexion under wet, dry , and humid
conditions. Use a modified ASTM adhesion scale to evaluate results. Compare to contro ls
Tegadenn and water-proof Band-Aids.
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•

Complete cyclic MTS testing with the bandage folding in compression under wet, dry, and humid
conditions. Use a modified ASTM adhesion scale to evaluate results. Compare to controls
Tegaderm and water-proof Band-Aids.

•

Compare the mechanical properties of the bandaging product with literature on mechanical
prope1ties of human skin.

•

Test the bandage ' s ability to elute chlorhexidine while completely immersed in phosphatebuffered saline solution with and without a cross-linked adhesive. UPLC analysis will be used to
quantify the release kinetics.

•

Complete MTS T-Peel adhesion testing with the rSSps bandages, Tegaderm , and water-proof
Band-Aids.

Background
Injuries to the skin occur by various modes and severities. Two major market s in which bandaging
improvements are needed include burns and pressure wounds (bedsore s). This study was conducted in
order to address specific needs for the treatment of burns , pressure wounds, and other serious healththreatening epithelial injuries.

Target Properties for Epithelial Wound Bandage
Epithelial wounds can be difficult to treat and therefore bandages targeted for these wounds must be
capable of meeting several requirements. Among the most impmtant prope1ties to consider are moisture
control, oxygen transfer, antimicrobial effect , biocompatibility, and mechanical attributes. The need for
moisture control can vary by wound type and severity. The ability of a bandage to absorb secretions of the
wound without causing excessive dryness is ideal. Oxygen transfer into the wound is also necessary for
proper healing mechanisms to occur, and thus it would be required for the bandage to be semi-permeable.
With a semi-permeable bandage , the risk of infection is heightened , and thus bandages must inhibit
bacterial infection. The most efficient bandages would also assist in the proliferation of epithelial cells
and act as a scaffold to facilitate cell regeneration. The mechanical properties of an ideal bandage would
closely mirror that of natural skin.

Pressure Sores and Bums
Pressure sores are one of the fastest growing problems among nursing home residents in the U.S. ln a
2004 study it was found that more than 1 in 10 nursing home residents had a pressure ulcer (Lee, Jeong,
Kang, Lee, & Park, 2009). This number will continue to increase as the baby-boomer generation reaches
retirement age and the nursing home population grow s. This will result in a significant financial burden
on the health care community and taxpayers. The annual cost for pressure ulcer management was $11
billion in 2006 (Moore & Cowman , 2013). Jointly , the need for effective treatment of pressure sores is
going to increase.
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Figure 1. Pressure Wound Stages .
Figure 1 illustrates common areas for pressure wounds to develop. The affected areas are often under
constant pressure from bedridden pati ents. Pressure wounds are most easily managed in Stages 1 and 2
before the wound penetrate s to the underlying musculature and bone as in Stages 3 and 4.
Treatment of pressure sores often proves to be very difficult. It is necessary to maintain a healthy
moisture balance in the wound. Wounds that relea se excessive moisture must be capable of drainin g the
excess fluid, and dry wounds mu st produce a great enough barrier to reta in needed moisture (O'Nei l,
2004). With bed sores in particular it is important that the bandage is gentle on the surrounding skin to
prevent maceration of the skin. As with any wound that breaches the ski n, it is important to ensure that
the wound does not become infected (Moore & Cow man, 2013). For this reason, antimicrobial bandages
are the most advantageous. Finally , the cost of the bandage and how often it need s to be changed are
important considerations for the pati ent and the medical indu stry .
The American Burn Association has estimated that 486,000 people per year receiv e treatment for burn s at
hospitals /bum centers. Costs associated with the se burn s total approximately $7 .5 billion ("American
Burn Association," n.d.). Burn treatment is difficult as contact with bum wo unds is very painful.
Bandaging must be able to cover a large surfac e area, protect against nosoco mial infection , and provide
an environment that facilitates cellular proliferation (Rowan et al., 2015). To prevent painful rem oval of
the wound dressing, having a bandage that slowly degrade s with time wou ld also be an immense benefit
to the patient.

Electrospun Bandages
Electrospinning is a process by which polar polymeric so lutions (called dope s) are used to create
nanofiber mats via high voltage application (Figure 2). Electrospinning began in 1934 and allowed the
production of nanofibers using a high electoral charge from a syr inge needle to a collector plate or drum.
The ability to produce mats made up of fiber s on the nanosca le offer a number of desirable prop erties.
First is the high surface area of bandage s produced by electrospinning . Thi s can be key in encouraging
hemostas is which can be vital to critical wounds (Karami, Rezaeian , Zahedi, & Abdollahi , 2013). This
surfa ce area to vo lume ratio also means that the bandages can be extremely absorptive. In the healing
proce ss, the body extrude s many liquid s and the ability of a banda ge to absorb this assists recovery. As
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discus sed earlier, bandages that allow a wound to breathe are more effective. Electrospun bandage s are
semi-permeable which mean s the wound will not dry up, but will also not be vulnerable to further
bacterial infection. The fine fiber size of electrospinning also allows electrospun bandages to contour to
any type of wound. The better a bandage can conform to a wound the more effective it will be and this
could be achieved in a numb er of ways with electro spun bandages. For example, pre-spun bandage s could
contour well due to their fine fiber size or bandage s could be electrospun directl y onto a wound to achieve
nearl y perfect conformation. An electro spun bandage can use a wide variety of polymers and be loaded
with substances such as antimicrobials and growth factors. Electrospun bandage s also can easily be made
bioactive by incorporating drugs into the fiber s. Last ly, the bandage s can act as a scaffo lding which
assists skin and veins in regro wth , leading to less scarring.

Jrt

.._
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Figure 2. Illustrat ion of electros pinning concepts.
Different polymers (specifically rSSp s) will be used to de sign several applications for wound covering.
Spider silk made up of biocompatible protein s known for their elasticity and strength (Lewis, 2006;
Panilaiti s et al., 2003). By using combinations of polym ers, the phy sical characteristics of the bandage
can be modified for specific applications /areas of the body. Dopes can be loaded with compound s before
being electrospun. The effectiveness of antimicrobial therap y will be explored when loaded into the
rSSps /polymer dope s.

Potential Applications of rSSps Bandage Material s
As a biopolymer , spider silk pre sents unique characteristics as compared to leading therapies. Spider silk
is bioc ompatible and thus will not interfere with natural healing processes( Lewi s, 2006). Antimicrobial
compounds and growth factors can be incorporated into the electro spun bandage and/or adhesive to
provide protection against infection and induce cellular regrowt h. Moisture control can be managed by
varying the thickne ss of the bandage as well as the amount of adhesive applied.
Mechanical properties of rSSp s are such that the applied bandage would w ithstand continued stress
without failure. rSSp s can be used as both the bandage material as an electrospun mat, and as the adhesive
to bind the mat to the wound. Electrospinning produce s fiber s in the nano- sca le, enabling small
5

molecules, such as oxygen , to pass through with little res ista nce . Because of the high surface-area-tovolume ratio of nanofibers , bandage s functionalized with antimicrobial compounds or growth factors will
release quickly and efficiently into the wound (Maleki, Latifi , Amani-Tehran , & Mathur, 2013).

Current Epithelial Wound Treatment
Currently, there are two main classes of bandage s. Pa ss ive bandage s see k to cover a wound to allow the
body to heal and recover underneath. They do little to help the body but prevent further infection of
injury. A commonly used example is gauze . Pas sive bandage s can inhibit healing because they do not
allow air into the wound which can cause the wound to dry up . Bioactive bandages, on the other hand,
seek to not only cover a wound but to allow it to breathe. They are more porous and allow water vapor
and oxyge n to the wound site which can help healing. Biological compounds can also be incorporated to
affect the chemical environment of the body and help it to heal. rSSps electrospun bandages would be
bioactive bandages which competes with current bandaging options.
Tegaderm is a commonly used product for pressure sores. This bandage boa sts a number of advantageous
propertie s. It is clear which enables the user to observe the wound without having to remove the bandage
repeatedly. It is water and oxygen permeable allowing the wound to " breathe " naturally . Th e bandage
prevent s bacterial contamination into the wound but doe s not have any propertie s to treat existing
bacterial infection. However , Tegadenn chlorhexidine gluconate (CHG) bandag es have been shown to
exhibit antibacterial prope11ies.

Literature Review
Electrospun Bandaging for Wound Therapy
Wound dressing s have significant potential for improvement as technologie s advance in fabrication
methods and available materials. Dre ssi ngs have developed from natural material s designed for bioinertness and have advanced to bioactive states, improving the healing proce ss beyond the body's natural
capabilities. Key players in this progre ss ion have been fabrication via electrospinning and the
incorporation of anti-microbial and anti-inflammatory agents. The purpo se of the se newer dre ssings is to
control the biochemical states of the wound.

In 2010 Zahedi et al. publi shed a review on wound dressing s with an empha sis on electrospun polymeric
bandage s (Zahedi, Rezae ian, Ranaei-Siadat, Jafari, & Supaphol, 20 I 0). In this review, a large variety of
polymeric compounds, such as alginates, cellulose, chitin, and hyaluronic acid have been extensively
studied. A challenge with many of these polymers is their limited solubility (Lee et al., 2009).
From the studies in the above reviews , only a small variety of antimicrobial additives were used , the most
common being ionic silver. The review found the release rate of the antimicrobials to be of supreme
imp011ance as the large surface area of electrospun fibrous mat s causes an initial bur st of antimicrobial
release followed by a severely lesse ned steady release rate (Zahedi et al. , 20 I 0). In order to combat the
initial burst , one group electrospun core-shell nano fibers with the antimicrobial compound inside of the
polym er to reduce the initial burst. This method effectively reduced the initial bur st release rate (Maleki et
al. , 2013) .
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Lna novel study published in 2012, Arenbergerova et al. produced a nanofiber textile doped with a
tetraphenylporphyrin (TPP) photosensitizer. When this compound is activated by visible light, it releases
a reactive oxygen compound that inactivates bacteria at the surface (Arenbergerova, Arenberger, Bednar,
Kubat, & Mosinger , 2012).
Several groups began experimenting with alternative biomaterials for preventing infection. In 2012
Karami et al. introduced thymol , an extract from thyme, into poly(e-caprolactone) (PCL), poly(lactic
acid) (PLA) electrospun mats. The group found thymol effective against both gram-positive and gramnegative strains of bacteria. Wounds treated with thymol had a closure rate of 92.5% after 14 days
(Karami et al., 20 I 3).
Ln 2015 a novel aspect of bandaging was introduced with the use of zwitterionic nanofibers created to
reduce cell adhesion to the dressing. Through their poly (carboxybetaine-co-methyl methacrylate)
copolymer, the group demonstrated that blood cells did not attach to the membrane and thus would not
cause clotting at the wound site (U nnithan et al., 2016).
Recent studies have had a large focus on anti-microbial additives, as anti-bacterial resistance and
nosocomial infection is becoming an ever greater issue in treatment. The other main area of focus is using
polymers that will have favorable reactions with living tissue. Arenbergerova presented a novel antimicrobial product; however , a light requirement could be problematic in situations where the patient has
limited mobility or the wound is in a hard-to-reach area.
Incorporation of naturally-occurring compounds such as thymol is an area with many possibilities and
potential for findings that could vastly improve current technologies in the medical field. Further research
should be done using biopolymers in combination with natural anti-microbial compounds for finding
effective methods of protecting the wound from infection and inducing healing mechanisms. This study 's
focus was to understand the interaction between electrospun rSSps mats /adhesives alongside the release
kinetics of antimicrobial/growth-inducing

compounds.

Spider Silk as a Biomaterial
Recombinant spider silk proteins have captured the attention of researchers for many years now. These
highly conserved protein sequences have endured millions of years of evolutionary pressure and ,
depending on the species, have uses ranging from prey capture to egg sac formation (Lewis, 2006). The
most notable and highly sought after silks are the major ampullate silks also known as dragline silk. As
nature's strongest biomaterial, dragline silk is tougher than Kevlar and stronger than steel by weight. This
remarkable combination of strength and elasticity has ignited numerous research projects to produce large
quantities of these proteins in transgenic hosts. The hurdles associated with this are the large size of the
native proteins (>250kDa) , purification and solvation of these proteins , and expression of these proteins
in transgenic hosts without truncation (Xia et al., 2010). Once produced, these naturally insoluble
proteins have been solvated using harsh organic solvents. However, using high heat and pressure it was
found that rSSps could be solvated in water, opening the door to a wide variety of biomedical applications
(Rising, Widhe, Johansson , & Hedhammar, 2011).
Spider silk's impressive mechanical prope11ies have yielded a lot of interest in the production of synthetic
spider silk fibers. Beyond fibers alone, it has been found that spider silks can be used to produce a wide
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array of materials such as fibrous mats, adhesives, coatings, films , hydrogel s, lyogels, and sponges (Jones
et al., 2015). The lack of an immun e response with respect to spider silk proteins has also led to numerous
research proj ects using silk products as cell scaffolding (Bauer, Wohlrab , & Scheibe), 2013). These
scaffolds allow for cells to attach and differentiate on a matrix that can then be transferred to a living
system.

Current Bandaging Hurdles and Research Associated with Epidermal Recovery
With new advances in biotechnology and biomaterials, research into wound healing and bandage s is
rapidly increasing . Normal bandages cannot provide the ideal conditions for wounds to heal properly , and
even contribute to conditions in which a wound could be further damaged. Current effmts include probe s
and sensors to manipulate the conditions of wounds dressed in conventional bandages (Mone, 2015).
One study showed the antimicrobial effects of chitosan acetate bandages on mice with burn wounds.
Although the bandages reduced inflammation , they also stuck to the wounds (Burkatovskaya, Castano,
Demidova-Rice , Tegos, & Hamblin, 2008). The consequence of a bandage that cannot be easily removed
is that the wound could be fu1ther damaged and the overall healing process could take longer (Mone,
2015).
Electrospun mats are currently being considered for use in the treatment of large wounds. The wounds
can heal relatively quickl y if covered in electrospun materials. The porous materials created from
electrospinning method s provide excellent barriers between the outside environment and the wounds they
are covering. They allow for gases to pass through , such as oxygen, but have sma ll enough pores to
prevent bacteria from passing (Wendorff, Agarwal, & Greiner, 2012).
Bandages typically involve some so1t of adhesive, and their ability to stick and be removed from the skin
can have a big impact on consumer's perception of the product s. However , the actual adhesive being used
is often overlooked in the design process. The future of smart bandages depends on the combination of
bandage and adhesive research ("Pressure-Sensitive Medical Technology").
Medical products, such as adhesives, must go through biocompatibility assessments to be approved for
human use. Researc hers in India cured polyurethane pressure-sen sitive adhesive tape by electron beam
and followed ISO guidelines to determine if their method produced a biocompatible product (Singh).
The aim of this project is to create a product prototype which combines innovative materials in bandages
and adhesives to create a "seco nd layer of skin" which promotes wound healing , protects against
microbial infection, and can be absorbed by the body. The bandaging system will be sp ider silk based,
making it more biocompatible than bandaging systems made from synthetic materials. A nylon-spider
silk electrospun mat is to be used in combination with a spider silk adhesive, either of which can be
loaded with antimicrobials and various growth factors to further promote healing.

Silk Products used in Epidermal Recovery
The use of silk polymer s for wound treatment has existed for thousands of years. However , toda y, much
res earch is being done to test the efficiency of these polymers as a biocompatible treatment. Some of the
advantages of using spider silk are argued to be its ability to be resorbed into the body and to not illicit an
immune response from the host. The largest challenge in creating a viable spider silk bandage is the
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ability to mass produce the spider silk protein and subsequently, spider silk thread and non-fibrous rSSps
products. This review will identify what work has been done and how it can be applied to the use of
electrospun spider silk as a viable wound treatment. A11icles will be reviewed for their application to this
project, supporting evidence, and scope of research.
The toxicity of silk proteins in epidermal applications is impo11ant and within the scope of this study to
explore. The topical application of a silk protein film has been used to test dermal irritation in rats and
hamsters using the Draize test (Padol et al., 2011 ). This a11icle offers a good animal testing scenario to
show that silk protein films are non-toxic when applied to the skin. On the other hand, it has too broad of
a scope in that the type of silk protein used is not clearly identified. It would be most valuable if spider
silk were the type used. The applications were all on healthy test subjects, not on those with any so11 of
wounds. It would be valuable to see the dermal response in a compromised area, such as a burn.
Studies have also been done to test the ability of spider silk fibers to serve as a scaffold for skin cell
culture. An a11icle by Wendt tested this possible application. This articles strengths came in using spider
silk fibers and testing skin culture regrowth, both of which would be valuable to the topic . However , the
at1icle uses a very simplistic model with limited replication or statistical analysis. The results show
potential for the application but miss the mark of offering definitive evidence (Wendt et al., 2011 ).
The applications of spider silk as a biomaterial has also been studies. An article by Vepari offers the most
extensive research and results. It is beneficial in showing past studies where silk has been used for tissue
scaffold applications. However, similar to the Padol article, the scope of this article may be too broad. It
uses a variety of silks and a variety of forms of the silk , rather than simply fibers or electrospun mats
(Vepari & Kaplan , 2007).
From this review, it can be dete1mined that spider silk offers a novel biomaterial in te1ms of its strength
and biocompatibility. However, there are still many areas which need to be researched. These articles
show that spider silk can be used without causing harm to the host and even encourage epidermal cell
regrowth. But the research lacks information regarding the use of electrospun spider silk and its potential
as a tissue scaffold. Also, no a11icle shows the effects of glutaraldehyde as a cross linking agent and the
potential toxicity associated with that treatment. Both of these would be valuable areas for fu11her study.

Design Process
A. Overview
The design process for this project was orchestrated with mechanical prope11ies, functionalization
prope11ies, and biocompatibility in mind. The different tests were designed to evaluate the mechanical
properties of the electrospun bandages as well as providing proof of concept for antimicrobial elution.
Because glutaraldehyde was used as a cross-linking agent in the fonnation of some of the electrospun
bandages, development of a cytotoxicity test was also necessary to evaluate the product's effectiveness
when exposed to living cells.
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Figure 3 shows the current concept map of ideas for this project. As the design progress continues , the
concept map will adapt to illustrate the decision making and the ideas that were pursued throughout this
project.
T-Peel

Mol-Sjny

Tenue
AgN Ps

SpiderSkin
Or,lo sian

nylon m4

BSA/Glutarnld
ehyde

Figure 3. Design process concept map showing the different ideas and methods of testing that were
explored in this study.

B . All Materials
•

Goat-derived recombinant spider silk protein s (rSSps): major ampullate spidroin I (rMaSpl) and
major ampullate spidroin 2 (rMaSp2)

•

97% Formic Acid

•

Distilled water

•

Pigskin

•

Electrospinner

•

MTS (Mechanical Testing System) Synergie I 00

•

MTS Cards (8 mm gage distance)

•

Optical Microscope
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•
•
•

Test Works 4 Software

•

Sprayer

•

Humidifier

•

UPLC Chromatographic System

•
•

End-over-end plate mixer

•
•

Digital Camera
Motic Imaging Software

Centrifugal Dryer
8 mL screw cap tubes with a flat base
Nunclon 24 we ll plate s

•
•

MRC-5 Lung cells

•

50% glutaraldehyde in solution

•

Tryp sin

•

ViCell

DMEM + I O¾FBS media

C. Selection of Mat/rSSps Adhesive Formulation
Rationale
Initial tests were chosen to decide what was the best formulation of electrospun mat and rSSps adhesive
to use for the continuation of the project. The following factors were evaluated: ease of spinning, material
availability, best adhesive prope1ties when combined with the electrospun mat.

Decisions
This initial thought process led to the decision to test the remaining three mat formu lations using the
criteria of ease of spinning, material availability, and performance using the on-skin pressure sensitive
tape test.
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Mat Formulation

Nylon

Nylon/rMaSpl

Other polymers

Nylon/rMaSpl/rMaSp2

Pros:opportunitesfor
biodegradability/better
mechanicalproperties
Cons:not enoughtime to
thoroughlytest all polymer
options

j
EliminatedBeforeTesting

Figure 4. Decision tree for rSSps mat/adhesive formulation

Materials
20% Nylon dope:
•

3 mL Formic Acid 97%

•

0.3 g Nylon (Rio 20# Monofilament)

10% Nylon + 10% rMaSp 1 dope:
•

3 mL Formic Acid 97%

•

0.3 g Nylon (Rio 20# Monofilament)

•

0.3 g rMaSpl

I 0% Nylon I 0% rSSps 80/20 rMaSp l/rMaSp2 dope:
•

3 mL Formic Acid 97%

•

0.3 g Nylon (Rio 20# Monofilament)

•

0.24 g rMaSpl (rSSps protein)

•

0.06 g rMaSp2 (rSSps protein)
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12% 50/ 50 rMaSpl/rMaSp2 rSSps adhesive:
•

3 mL distilled water

•

0.18grMaSpl

•

0.18 g rMaSp2

12% 50/ 50 rMaSp I /rMaSp2 + 1% Glutaraldehyde rSSps adhesive:
•

I mL 12% 50/50 rMaSpl/rMaSp2 rSSps adhesive

•

20 µI 50% glutaraldehyde stock

12% 50/50 rMaSpl/rMaSp2 + 1% Glutaraldehyde + 10% Bovine Serum Albumin rSSps adhe sive:
•

I mL 12% 50/50 rMaSp l/rMaSp2 rSSps adhesive

•

20 µI 50% glutaraldehyde stock

•

0. lg 96% bovine serum albumin lyophilized powder

Methods
Mat formulation:
For this test there were 3 different initial mat formulations tested: 20% nylon , I 0% nylon I 0% rMaSp I
protein, and 10% nylon 10% 80/20 rMaSpl /rMasp2 proteins, all of which were dissolved in formic acid .
The method for dope preparation as well as the spinning protocol is explained in detail in Appendix A.
Three spins (I ml dopes for each spin) were completed for each of these formulations and were monitored
for ease of spinning. The criteria for this was : the thickness of the mat created , how well the mat could be
manipulated by hand without falling apart, and how many drops were created from the dope solution
during the spin that altered the effectiveness of the final mat. Availability of materials wa s also
considered during this test.
Adhe sive formulation:
There were 3 different initial adhesive formulations tested: 12% 50/50 rMaSpl/rMaSp2 rSSps adhesive ,
12% 50/50 rMaSpl/rMaSp2 + 1% Glutaraldehyde adhesive, 12% 50/ 50 rMaSpl/rMaSp2 + 1%
Glutaraldehyde + 10% bovine serum albumin adhesive. The method for the adhesive preparation is
further explained in Appendix A. The ease of production and application of each adhesive formulation , in
combination with each mat formulation was the initial criteria in deciding which adhe sive to use.
Pressure-sensitive tape test:
Thi s test wa s conducted to narrow the choices for the mat and rSSps adhesive. The methods for this test
were derived from ASTM 03359-09 . Fresh pigskin was cleaned and shaved as detailed in Appendix C
and electro spun mats wer e prepared according to the protocols in Appendix A. The rSSps adhesives were
prepared in three different formulation s: 50/50 rMaSpl :rMaSp2, 50/50 rMaSpl :rMaSp2 with I%
glutarald ehyde , and 50/50 rMaSp I :rMaSp2 with I0% bovin e serum albumin (BSA) . Different ratio s of
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rMaSp 1 and rMaSp2 were not explored because previous research has shown these goat-derived rSSps
adhesives constitute the best mechanical properties (Jones et al., 2015). The different electrospun mats
were cut into 5 cm x 2.5 cm rectangular samples. Five samples of each of the three mats were applied and
adhered to the fresh pigskin with each of the three rSSps adhesives and left to dry for approximately 35
minutes. Once the mats were dry , 1 cm X-shaped incisions were made to the mats and covered in small
pieces of painting tape. The tape was peeled off from the mat and results were based on a 0-5 sca le as
follows:
Table 1. Pressure-Sensitive Tape Test Grading Scale
SA

No peeling or removal

4A

Trace peeling or removal along incisions or at their intersection

3A

Jagged removal along incisions up to 1.6 mm on either side

2A

Jagged removal along most of incisions up to 3 .2 mm on either side

IA

Removal from most of the area of the X under the tape

OA

Removal beyond the area of the X

Scanning Electron Microscopy:
SEM imaging was used to evaluate the surface conditions of the electrospun mat/rSSp s adhesive
complex. The qualitative analysis of the bandage material was to see the adhesive /mat matrix and how the
adhesive permeated the fibers. This was one of the first steps in the initial characterization of the
bandaging product.

Results
The SEM images indicated that there was an infiltration of the rSSps adhesive into the fibrous pores of
the electrospun mat, causing it to change from a white material with no transparency to a material with
complete transparency. This imaging was the first step in the characterization of the bandaging product.
No major difference was seen in the su1face characteristics of the different materials, however it became
clear that the adhesive saturated the surface to the point that the individual fibers were no longer visible
(Figure 5).
Table 1 illustrates how the different mat/rSSp s adhesive combinations performed for the three criteria:
ease of electrospinning, material /protein availability , and the pressure-sensitive tape test performance. All
were analyzed on a 0-5 sca le. The pressure-sensitive tape test scale is shown above and the numbers
reported below are an average score with n=5. From these results, it was decided to move forward with
the rest of the study using a 10% Nylon: 10% rMaSp I mat due to the fact that it was relatively easy to
spin and interacted better than the other two mats with the rSSps adhesive s. As for the rSSp s adhesives ,
the rest of the study moved forward using two adhesives: the 50/50 rMaSp I :rMaSp2 adhesive and this
same adhesive with I% glutaraldehyde added as a cross-linking agent. It was noted during these
experiments that the 1% glutaraldehyde adhesive was easier to work with than the other adhesives and it
was given a good score on the pressure-sensitive tape test s. It was decided that this cross -linking agent
was of interest in this study, therefore all future study include s an analysis of both thes e adhesives.
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Table 2. Criteria Comparisons for Mat/rSSps Adhesive
Criteria Weight

a

20% Nylon Mat

10% Nylon / 10%

10% Ny lon/ I 0%

rMaSpl

50/50
rMaSp 1:rMaSp2

Spinning: 0.3

Spinning: 5

Spinning: 4

Spinning : 3

rMaSp I :rMaSp2

Availability: 4

Availability : 4

Availabi lity: 2

Adhesive

Tape Test: 3

Pressure- sensitive

Pressure-sensitive

TOTAL: 3.9

Tape Test: 4.5

Tape Test: 4

TOTAL: 4.2

TOTAL: 3.1

Spinning: 5

Spinning: 4

Spinning: 3

rMaSp 1:rMaSp2

Avai lability: 4

Availability: 4

Availability: 2

Adhesive w/ I%

Tape Test: 3

Pressure-sensitive

Pressure-sensitive

glutaraldehyde

TOTAL: 3.9

Tape Test: 5

Tape Test: 4

TOTAL: 4.4

TOTAL: 3.1

Spinning: 5

Spinning: 4

Spinning: 3

rMaSp 1:rMaSp2

Availability: 4

Availability: 4

Availability: 2

Adhesive w/ 10%

Tape Test: 1

Tape Test: I

Tape Test: I

BSA

TOTAL: 3.1

TOTAL: 2.8

TOTAL: 1.9

50/ 50

50/50

Availability : 0.3

50/50

Tape Test: 0.4

..

a. Ease of sp111n111g,
ava1lab1lity of material, and the pressure-sens1t1vetape test were given weights of importance of 30%, 30%, and 40%
respectively.
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Figure 5. SEM images at 5000x magnification. (A) Nylon-rMaSp I electrospun mat with 50/50
rMaSpl :rMaSp2 adhesive , (B) Nylon-rMaSp2 mat control with no adhesive
Conclusion
By doing a criteria comparison test using the criteria: ease of spinning, material availability , and the
pressure sensitive tape test results it was possible to eliminate the mat fonnulations of 20% nylon , and
I 0% 50/50 rMaSp I /rMaSp2 with 10% nylon. Using a combination of all of these criteria , the project was
able to move forward with a mat formulation that performed well on skin, was easy to electrospin, and all
materials for this formulation were readily available. Of course , much more research could be done to
optimize this mat formulation, perhaps creating a mat that is made of only rSSps or including polymers
that have different levels of biodegradability and testing how these polymers interact with the rSSps.
The SEM imaging allowed for the qualitative analysis of the bandaging product and allowed for a visual
representation of the interaction between the nanofibers of the electrospun mat and the rSSps adhesive.
The adhesive covers and encompasses these nanofibers as was hypothesized.

D. T-Peel Testing
Rationale
T-peel testing was conducted to test the strength of the adhesives compared to already existing medical
adhesives. This test was derived from ASTM F2256. Water-proof Band-Aids and Tegaderm tape were
used as controls for comparison. Only the clear adhesive portions of these control bandages were used so
that a direct adhesive comparison was possible.

Decisions
Due to the fact that this was the first on-skin quantitative test the decisions made during this testing period
were carried through for the remainder of the design process. Therefore, the same controls and the same
environmental testing conditions were carried out in all mechanical testing thereafter.
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Figure 6. Decision Tree for T-Peel Testing.

Materials
•

MTS (Mechanical Testing System) Synergie l 00

•

Humidifier

•

Distilled water

•

Water-proof Band-Aids

•

Tegagerm dressing

•

Pigskin

•

Sprayer

l 0% Nylon + l 0% rMaSp l dope:

•

3 mL Formic Acid 97%

•

0.3 g Nylon (Rio 20# Monofilament)

•

0.3 g rMaSpl

12% 50/50 rMaSp l/rMaSp2 rSSps adhesive:
•

3 mL distilled water
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•

0.18 g rMaSp 1

•

0.18grMaSp2

12% 50/ 50 rMaSp I /rMaS p2 + 1% Glutaraldehyde rSSps adhesive:
•

1 mL 12% 50/50 rMaSp l/rMaSp2 rSSps adhesive

•

20 µI 50% glutaraldehyde stock

Methods
Strips of pigskin were prepared according to Appendix C so that one 0.5 cm x 2.5 cm electrospun mat or
control strip fit on each strip of skin. Of the 60 mat strips glued onto the strips of pigskin , 30 were glued
with the 50/50 rMaSp I :rMasp2 adhesive and 30 were glued with the rMaSp 1:rMasp2 + I%
glutaraldehyde adhesive. The properties of the adhesives were subjected to three different conditions: dry,
humid, and wet. These conditions are provided in more detail in Appendix D.
As seen in Figure 7 an edge of each mat or test control was pulled up from the skin to fit into the top MTS
grips, while the skin was secured to the bottom grip. As the top grip moved up the bandage system was
peeled off of the skin. The samples were pulled off at a rate of 2.5 mm/min, and the average load to peel
the sample off of the skin was measured. This test was derived from ASTM F2256.

Figure 7. Illustration of T-Peel Adhesive Testing.

Results
The maximum load recorded was compared between the groups in dry, humid, and wet conditions (Figure
8). Stati stical analysi s was performed via JMP ® software. The visual outputs of JMP ® are explained in
Appendix F.
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The rSSps adhesives with and without glutaraldehyde were shown to have an adhesive strength between
that of Tegaderm and Band-Aids. Band-Aids proved to have the greatest adhesion to the skin, while
Tegaderm was con sistently one of the lowest. The rSSps samples showed no significant difference in
adhe sive strength between the wet, dry , and humid conditions tested . However , the rSSps and
glutaraldehyde adhesive sample s tested under dry and wet condition s exhibit ed higher adhesive strength
than the rest of the samples , except for the Band-Aid samples tested under the same conditions. The
sample s are arranged into statistically significant groups in Figure 9.

-

.

.

L1Connecting letters Report
Level

Mean

BandAid Dry
A
0.799 10950
BandAidW et
0.67611520
A
8andAid Humid
B
0.45042420
ss~Glu Wet
BC
0.40 291775
SS+Glu Dry
B C D 0.344 10333
SS Dry
C D E 0.26340756
SSWet
D E 0.22964380
Tegaderm Wet
E 0.16771344
SS+Glu Humid
E 0.15617375
E 0.15597560
SS Humid
Tegaderm Humid
E 0.139 97490
E 0.13303520
Tegadem1 Dry

Figure 9. Stati stical Grouping s of T-Peel test s
Conclusion
The rSSps and rSSps with glutaraldehyde adhesive sample s matched or exceeded the adhesive strength of
commercially-available Tegaderm, but did not adequately compare to the Band-Aid sample s for this
specific test. The results indicate that the rSSps adhesive s are capable of competing with commercial
products in the adhesive realm.

E. Cyclic Fatigue Testing with Bandages in Compression
Rationale
Cyclic fatigue te sting in compre ssion was conducted in order to evaluate the efficacy of the bandage
under cyclic compres sion. This scenario would be seen in real-lif e application when the bandage is
applied near or on joints . The ability of the bandaging material to stay intact and adhered onto the skin
when compression lines are formed was considered vital for the stability of the product.
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Decisions
Design of test method

Humid Conditions

Wet Conditions

Dry Conditions

Figure 10. Decision tree for cyclic fatigue testing with bandages in compression.
Materials
•

MTS (Mechanical Testing System) Synergie 100

•

Humidifier

•

Distilled water

•

Water-proof Band-Aids

•

Tegagerm dressing

•

Pigskin

•

MTS Cards (8 mm gage distance)

•

Sprayer

I 0% Nylon + 10% rMaSp I dope :
•

3 mL Formic Acid 97%

•

0.3 g Nylon (Rio 20# Monofilament)

•

0.3 g rMaSpl

12% 50/ 50 rMaSp I /rMaSp 2 rSSps adhesive:
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•

3 mL distilled water

•

0.18grMaSpl

•

0.18grMaSp2

•

0.03 µI Glutaraldehyde (50% stock solution)

•

0.1 g Bovine Serum Albumin (BSA)

12% 50/50 rMaSp I /rMaSp2 + I% Glutaraldehyde rSSps adhesive :
•

I mL 12% 50/50 rMaSp 1/rMaSp2 rSSp s adhesive

•

20 µl 50% glutaraldehyde stock

Methods

Nylon /rMaSp 1 mats were cut into 0.5 cm x 2.5 cm strips and glued in group s of 3-4 unt o prepared pieces
of skin with the rSSps adhesives (with and without glutaraldehyde). Once dry, the piece s of skin were
secured on the MTS by grips on the top and bottom sides, with the mats oriented upright (Figure 11). The
MTS was programmed to move the top grip at a rate of 5 mm/sec up and down I 00 times bending the
skin to about 90° to create cyclic stress, compressing the bandage . The testin g wa s conducted und er three
different conditions (wet, dry, humid) according to Appendix D. After the testing was completed the
adhesion of the bandage material (either control bandange or electrospun mat formulation) were evaluated
according to the sca le detailed in Table 3. The ratings were done by the same individual to avoid
differences in rating style and personal preference. Statistical analysis was performed via JMP ® softwa re.
The visual outputs of JMP ® are explained in Appendix F.
Table 3. Cyclic fatigue in compression grading scale
SA
No peeling or removal
Trace peeling or separati on from the substrate
4A
3A

Half of the bandage is separated

2A

More than half of the bandage is separated

lA
OA

Most of the bandage is separated
Full separation

22

Figure 11. Illustration of compression cyclic testing using the MTS .
Results
Following statistical analysis, all variations of SpiderSkin (with and without glutaraldehyde) were in the
same statistical grouping as the commercial bandage material Tegaderm. Furthennore, under this
compressive testing , water-proof Band-Aids were significantly worse in wet conditions than all other
groups due to the separation of the the bandage material as the compression lines were manipulated and
moisture got underneath the bandage.

23

~
r;a·

.,=

i-

~

.....
N
()
0

BandAid

Fatigue Compressio n

-

N

w

-- L

oJ,
'!

3

-0

u,

J>.

. ---~-1
<(.
"

J

..,
$:I)

I

(1

I

cii'

'

0

::i

BandAid Humid

0
.....,

C)

..,
0,.

ro
rn

BandAid We~

o'
..,
()
0

•

•

I

1

3

..,

-0

<v
•

i

ro
rn

•

ssol

rn

<:'
ro

.,1 '

~

~

I

oci'
i::

ro
-l
ro
rn

)·

i/

I
·!
I

'Tl

•

\

1

$:I)

I)

•

SS Humid

•

{I

I) •

II

.....

s·

l

(IQ

~\

SS Wet
~

3
-u
iii

•

a

•

SS+Glu Dry

I

l
I

•

SS+Glu Hum iA

SS+GluW e•·

Teg,d" m

Dl

•

•

Tegade rm Humid,

.l
I

•

Tegaderm Wet
N

""

L_

--·--

-----

- --- · ···
--·------------'

<>
•

.oConnecting Letters Report
Level

Mean

BandAid Dry
A
4.9000000
SS+GluDry
A
4.9000000
SS+Glu Wet
A
4.9000000
Tegaderm Wet
A
4.9000000
Tegaderm Dr;
A
4.8000000
SS+Glu Humid
A
4.7000000
SSDry
A
4.6000000
SS Humid
A
4.6000000
Tegaderm Humid A
4 .5000000
BandAid Humid A
4.3000000
SS'Net
A
4.2000000
BandAid Wet
B 3.1000000
levels not connected by same letter are significantly different.

Figure 13. Connecting Letter s Repo1t for Compressive Fatigu e Testing
Conclusion
All groups pe1formed s imilarl y, w ith the exception of Band-Aid which had significantl y reduced adhesion
under cycl ic compression in wet condition s. Both glutaraldehyde and non-glutaraldehyde bandages were
comparab le to commercially available product s. The rSSp s adhe sives with and without glutaraldehyde
exh ibited an ability to maintain adhesion of the nylon/rSSps mat under compression even in wet and
humid conditions.

F. Cyclic Fatigue Testing with Bandages in Flexion
Rationale
Th is test , similar to the cyc lic fatigue testing in compression, will be used in evalu ating the efficacy of the
bandage under repeated flexion. Thi s will occur most intensely when the bandage is applied to a joint.
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Decisions
Design of test methodflex bandage at same
position

Wet Conditions

Figure 14. Decision tree for cyclic fatigue testing with bandages in flexion
Materials
•

MTS (Mechanical Testing System) Synergie 100

•

Humidifier

•

Distilled water

•

Water-proof Band-Aids

•

Tegagerm dressing

•

Pigskin

•

MTS Cards (8 mm gage distance)

•

Sprayer

I0% Nylon + 10% rMaSp I dope:
•

3 mL Formic Acid 97%

•

0.3 g Nylon (Rio 20# Monofilament)

•

0.3 g rMaSp I
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12% 50/50 rMaSp 1/rMaSp2 rSSps adhesive:
•

3 mL distilled water

•

0.18grMaSpl

•

0.18grMaSp2

•

0.03 µI Glutaraldehyde (50% stock so lution)

•

0.1 g Bovine Serum Albumin (BSA)

12% 50/50 rMaSp l/rMaSp2 + 1% Glutaraldehyde rSSps adhesive:
•

1 mL 12% 50/50 rMaSp l/rMaSp2 rSSps adhesive

•

20 µI 50% glutaraldehyde stock

Methods
The nylon/rSSps electrospun mats were cut into 0.5 cm x 1.5 cm strips and two mats were applied to the
center of square shaped pieces of pigskin with the rSSps , or rSSps + glutaraldehyde adhesives and left to
dry. To set up the flexi on test, each piece of skin was secured between two frames, screwed into place to
prevent movement of the skin, and a rod with a rounded top was used to push the skin 10 mm upward .
Figure 15 shows this set up. The thickness of these skin piece s averaged 13 mm.

:u__

Figure 15. Flexion Testing (A) illustrates the flexion apparatus. (B) Illustrates the testing with the pigskin
loaded in the apparatus.

Results
Grades were given to the bandages in dry , humid, and wet condition s (Figure 16). Statistical analysis was
performed via JMP® software. The visual outputs of JMP ® are explained in Appendix F.
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In contrast to the compressive fatigue test detailed above, there was much more variation between groups
in flexion fatigue testing. The rSSp s adhesive withstood fatigue testing similar to Band-Aid and exceeded
the results ofTegaderm. The groups are further detailed in Fig ure 17.
L1Connecting Letters Report
Level

SSHumid
BandAidHumid
SS+GluHumid
BandAidDry
SSWet
SSDry

SS+Glu Dry
SS+Glu Wet
Tegaderm Dry
BandAidWet
Tegaderm Humid
TegadermWet

Mean
A
A B

A
A
A
A
A

8
8
8
B
BC
8 C
BC

4.8000000
4.6000000
4.5000000
4.4000000
4.1428571
4.0000000
3.4000000

3.2000000
3.2000000
2.4000000
2.0000000
1.6000000

C D
C D
D
levels not connected by same letter are significantly different.

Figure 17. Connecting letters repo1t for cyclic flexion testing.
With the exception of the rSSps adhesive with glutaraldehyde as a cross-linker, the rSSps adhesive alone
was not statistically diff erentiable from water-proof Band-Aid. The rSSps adhesive with glutaraldehyde in
the wet condition was significantly different from Band-Aid in wet conditions, as well as matche s or
exceeds Tegaderm and Band-Aid in every condition tested, respectively.

Conclusion
This test showed that the adhesive propertie s of both the rSSp s and the rSSps + glutaraldehyde bandages
under dry, wet, and humid conditions were not affected to the same degree as the Band-Aid and
Tegaderm. Although adhesive strength not increased with the addition of glutaraldehyde, the performance
of the rSSps adhesive under wet and humid conditions suggests it would be a good alternative for
dressing wound with very high moisture levels.

G. Tensile Testing of Materials
Rationale
Ten sile testing was conducted to compare four basic mechanical propertie s: toughness, elastic modulu s,
strain at failure, and ultimate tensile strength. The prope1ties of the electrospun mat with applied
adhesives were compared to Tegaderm and water-proof Band-Aid, as those products contain similar
mechanical prope1ties to those desired of the final product.
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Decisions
TestingMethod

Figure 18. Decision tree for tensile testing.
Materials
•

MTS (Mechanical Testing System) Synergie 100

•

Humidifier

•

Distilled water

•

Water-proofBand-Aids

•

Tegage1m dressing

•

Pigskin

•

MTS Cards (8 mm gage distance)

•

Optical Microscope

•

Digital Camera

•

Motic Imaging Software

•

Test Works 4 Software

•

Sprayer

I 0% Nylon + 10% rMaSp 1 dope:
•

3 mL Formic Acid 97%

•

0.3 g Nylon (Rio 20# Monofilament)

•

0.3 g rMaSp I
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I 2% 50/50 rMaSp 1/rMaSp2 rSSps adhesive:
•

3 mL distilled water

•

0.18 g rMaSp I

•

0.18 g rMaSp2

•

0.03 µI Glutaraldehyde (50% stock solution)

•

0.1 g Bovine Serum Albumin (BSA)

12% 50/50 rMaSp J/rMaSp2 + I% Glutaraldehyde rSSp s adhesive:
•

1 mL 12% 50/ 50 rMaSpl/rMaSp2 rSSps adhesive

•

20 µI 50% glutaraldehyde stock

Methods
Ten samples were co llected per nylon/rSSp s mat and five per control (Tegaderm and Band-Aid). Thin
film s were cut and applied to an 8 mm gage before being loaded in tensile. Testing was conducted in dry,
humid (appro ximatel y 100%), and wet conditions, to mimi c possible state s of wounds in patient therapy.
The testing wa s continued until failure of the sample, with samples being pulled at 5 mm/min.

Results
Data were conve1ted into stress/strain curves, and various mechanic al properti es were calculated in their
individual spheres. The se data were passed on for mean com parison via Analysis of Variance (ANOVA) ,
and individual t-Te sts. Statistical analysis was performed via JMP ® software. The visual outputs of
JMP ® are explained in Appendix F.

Toughness:
Tou ghness is an impo1tant mechanical property of the banda ging complex, as the bandage must be
resistant to failure upon excessive stresses. Tougher skin is more durable , and therefore able to withstand
continuous motion and manipulation by the patient. Human skin was found to have an average toughness
of 4.9 ± 1.5 MJ/m 3 (Gallagher et al.).
The toughnes s of the variation s of SpiderSkin as compared to commercial product s is shown in Figure 19.
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It was noted that the rSSps mat and adhesive complexes did not demonstrate toughness similar to that of
cun-ently available products, but exhibited toughness more comparable to human skin. This result is
mainly due to the relative rigidity of the electrospun mat. The Tegaderm and Band-Aid controls were
capable of absorbing a considerably higher amount of energy before failure, and thus are more likely to
withstand the patient ' s motion. In the following Connecting Letters Repo1t, the sample s are grouped by
their statistical significance (Figure 20).
LI. Connecting Letters Report
Level

BandAid Wet
BandAidHumid
TegadermWet
BandAid Dry
Tegaderm Humid
Tegaderm Dry
SS-1-Glu
D1y
SS+Glu Wet
SSHumid
SSWet
SS-+GluHumid
SS Dry

Mean

A

195 .32290
194.6 0469

A B

183.966n

AB

16 3.04293
145.4704 2
139 .53501
39.6 1657
31 .30083
28. 88110
15.27153
11.59025
4 .82244

A

A 8
8

C
C
C

C
C
C

Figure 20. Toughne ss grouped by statistical significance.

The mean toughness for the rSSps bandaging complex experimental groups were con siderably less than
that of Band-Aid or Tegaderm, however they have similar toughne ss to that of human skin in all cases .
Similar toughness to skin could potentially provide better mechanical suppo1t to a larger wound.

Elasti c Modulus:
The modulus of elasticity measure s the material 's resistance to elastic deformation. A high elastic
modulus denotes a material that is inelastic , usually in the GPa range. For a bandaging application, a very
inelastic material would bring discomfott as the bandage would not change with the patient. A very low
modulus of elasticity would also be undesirable, as the bandage would not provide necessary
support/protection to the wound. Human skin was found to have an average elastic modulus of 98.97 ± 97
MPa, a highly variable value due to the anisotropic nature of human skin as well as the differences of skin
propetties in different areas of the body(Gallagher et al., n.d.). The elastic moduli of the rSSPs bandaging
system and commercially-available products is shown in Figure 21.
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The elastic moduli for the rSSps bandages were much greater than Tegaderm /Band-Aid. [n dry
conditions, this difference was accen tuated. Comme rcial products, likely due to their water-proof nature ,
did not show much variance in wet, dry, or humid conditions. As the ny lon/ rSSps mat is semi-permeable,
the water could be absorbed by the bandage and result in a lower modulus of elasticity more similar to the
elastic modulu s observed in human skin. Significantly different samples are labeled in Figure 22 .
.!l Connecting Letters Report
Level

SS+GluDry
A
SSDry
AB
SSWet
BC
SS+Glu Humid
BC
SSHumid
C
C
SS+Glu Wet
BandAidDry
C
BandAidHumid
C
C
BandAidWet
Tegaderm Wet
C
Tegaderm Dry
C
Tegaderm Humid
C

Mean
264 .13537
178.35313
119 .51718
48.30444
25.02537
20.16460
4 .98768
3.83313
3. 63242
3.36926
2.89122
1.64 317

Figure 22. Modulus of elasticity gro uped by stat istica l significance.

Strain at failure:
Strain at failure denote s the exte nt to which a mater ial can be deformed without failure. ln a bandaging
application, the bandage should be able to withstand strain at failure equal to or greater than what the
natural skin can withstand . In human skin, average stra in at failure values were found to be 25.45 ± 5.07%
(Gallagher et al.). The strain at failure of the rSSps bandages and commercially-available product s is
shown in Figure 23.
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The highl y elastic nature s of Tegaderm and Band-Aid can be noted in above Figure 23. As has been
observed previou sly, the rSSps bandage becomes more elastic in humid and wet conditions condition s.
The samples are grouped by statistical s ignificance in Figure 24.
Ll Connecting Letters Report
Level
Tegaderrn Hu mid A
BandAid Humid
8
8
BandAid Wet

Tegaderm Dry
Tegaderm Wet
BandAid Dry

Mean

727.83927
601 .73479
579.58 185

8
8

C

SS Humid

D

SS+Glu Wet
SS~Glu Hum id

DE
DEF
DEF

SS+Gl
u Dry
SSWet
SS Dr/

EF
F

575.19696
547.14594
47 2.908S4
70.02188
66.49676

3s.,sno
24 .60110

20.68700
9.56714

Figure 24. Strain at Failure Grouped by Statistical Significance.
As noted in the elastic moduli sectio n, the rSSp s bandage comp les is not as elastic at the Tegaderm and
Band-Aid controls. The rSSps /nylon bandage s resulted in considerably lowe r strain at failure values than
the Tegade1m or Band-Aid controls, however the values were much closer to the 25% strain typical of
human skin . In dry conditions , spider silk underperformed the strain at failure of skin, but in a wound
application, the bandage is more like ly to be under high moisture condtions.

Ultimate Tensile Strength:
Ultimate tensile strength denotes the maximum resistance to elongation exhibited by the material at any
point before failure. The average ultimate tensile strength of human skin was found to be 27.2 ± 9.3 MPa
(Gallagher et al.). Optimal values would mimic the natural skin, as a higher value could lead to
disco mfort when the skin is able to stretch more than the bandage, and a lower value could lead to
bandage inefficiency. The ultimate tensile strength of the rSSp s bandaging structure and commerciallyavailable product s is shown in Figure 25.
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Ultimate ten sile strength was the most similar of any tested parameter. On average , rSSps formulations
exceeded the values of both Tegadenn and Band-Aid , however , as can be seen in Figure 26 , these values
were often ins ignificant.
.:::IConnect ing Letters Report
Level

SS+Glu Dry
SSWet
SS+GluWet
SS Dry
SS+Glu Humid
SSHumld
Tegaderm Wet
BandAid Humid
BandAid Wet
BandAid Dry

Mean

A

B
BC
BC
BC
BC
BC

D
D
D
D

C D

C D
C D

Tegaderm Dry

D

Tegaderm Humid

D

37.595118
25.081620
22.403089
18.2 52513
15.664019
15.401418
13.100770
11.449 892
10 .90 1183
10 .59 1657
8.904093
7.84 1741

Figure 26. Ultimate tensile strength group ed by stati stical significance.

The rSSps adhesive formulations were not significantly higher than Tegaderm or Band-Aid, however the y
were closer to the average ultimate tensile strength for human skin. The rSSps adhesives in wet
environment s resulted in the closest values to that of human skin.

Conclusion
The rSSps adhesives, both with and without glutaraldehyde , replicated the mechanical propertie s of
human skin closer than either commercial product, Tegaderm or Band-Aid. The toughness of both rSSps
adhesive /mat formulations were significantly less than that of the commercial alternatives , but more
similar to the value of human skin . The elastic moduli of the rSSps adhesive /mat formulations were
higher than Tegaderm or Band-Aid , but again closer to human skin. The bandage failed at similar values
to human skin, which was much lower than the strain failure value s found for Tegaderm and Band-Aid.
The most similar property to human skin for the rSSps adhesive /mat compl ex was the ultimate tensile
strength , in which very little statistical significance was found between groups, and most were below the
strength of human skin.
From the data that were collected, it was sugge sted that a "second skin " made from an rSSp s adhesive a
nylon /rSSps electrospun mat could match the mechanical propet1ies of skin . In contrast to Tegaderm and
Band-Aid , the rSSps adhesive has the potential to be loaded with growth-inducing and/or anti-microbial
additives. An application of this loading will be demonstrated hereafter.

H. Chlorhexidine Gluconate Release
Rationale
Chlorhexidine gluconate is an antimicrobial compound useful in preventing infection. This testing was to
evaluate the chlorhexidine release when incorporated into the bandage through the rSSps adhesive. This
simultaneously tested the strength of the interaction between adhesive and mat complex and whether the
addition of glutaraldehyde increases this interaction.

Decisions

TestingMethods

After consultationwith
biomedicalcompanies,
chlorhexidinewas chosenas
the most plausibleoption for
this application

Antimicrobial In electrospun
fibers (ideal scenario)

Spinning efforts were
unsuccessful-needs more
research

Antimicrobial in adhesive

Would allow for all over
antimicrobial release in the
wound

Chosen as the only current
option for this project to test
an antimicrobial release

Figure 27. Decision tree for chlorhexidine gluconate release.
After the decision was made to only include the antimicrobial in the adhesive for this particular test, it
was decided to test the mat/adhesive complex for antimicrobial release under total immersion in
phosphate-buffered saline. These testing conditions would illustrate the fastest release possible for the
bandaging material and allow for the best opportunity for a controlled experiment. However, a wound
environment will have va1ying levels of moisture and the bandaging material would likely never be
completely submerged as was done in this experiment.

40

Materials
•

UPLC Chromatographic System

•

Acquity UPLC BEH C 18 Column

•

Centrifugal Dry er

•

Phosphate-buffered saline

•

6 well cell culture plate

10% Nylon + 10% rMaSp 1 dope:
•

3 mL Formic Acid 97%

•

0.3 g Nylon (Rio 20# Monofilament)

•

0.3 g rMaSp 1

12% 50/ 50 rMaSp l/ rMaSp2 rSSp s adhesive:
•

3 mL distilled water

•

0.18 g rMaSp I

•

0. 18 g rMaSp2

•

0.03 µI Glutaraldehyde (50% stock solution)

12% 50/50 rMaSpl /rMaSp2 + 25% Chlorhexidine gluconate-loaded adhe sive :
•

1 mL 24% 50/ 50 rMaSp l/rMaSp2 adhesive

•

1 mL 50% chlorhe x idine stock solution

Methods

In this study, three sets of experimental samples (n = 2) were prepared. These three experimental sets
were one set of nylon/rMaSp I electrospun mat s with no adhesive and two sets of nylon /rMaSp 1
electrospun mats coated with the two different adhesives: 50/ 50 rMaSp 1:rMaSp2 and 50/50
rMaSp 1:rMaSp2 with 25% glutaraldehyde. These two sets including the rSSp s adhesive included
chlorhexidine gluconate to a final concentration of 25%. Analysis of the relea se was completed with ultra
perfonnance liquid chromatography (UPLC) and results were analyzed using a previou sly prepared
standard release curve for chlorhexidine gluconate .
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The electrospun mats and adhes ives were prepared according to the methods detailed in Appendices A
and B. Once these samp les we re prepared, they were each placed in 5 mL of l x pho sphate buffered sa line
in individual wells of a six -we ll ce ll culture plate. Initial I mL samp les from each we ll were taken. The
well plate was then placed in a 3 7 °C incubator. 1 mL samples were taken from eac h we ll at 24-ho ur
intervals for 14 days. Each day, a ll of the pho sphate-buffered sa line was replaced , and the samp les were
placed in a dry six -we ll plate wit h a fres h 5 mL of phosphate-buffered

sa line.

Results
T he ana lysis of chlor hexid ine re lease showed a release for both SpiderSkin formulat ions up to fo ur day s.
Th e rSSPs adhes ive with g lutaraldehyde exhib ited a seco ndaiy peak at about three days, indicat ing that
the cross-li nking age nt aided in the interactio n between nanofiber and rSSP s ad hesive. T he release
profiles can be see n in Figure 28.

Chlorhexidine Gluconate Release Profiles
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Figure 28. Ch lorhex idin e gluconate release profile from standard rSSp s mat/adhesive comp lex w ith no
cross -link ing.

Conclusion
The ch lorhexid ine gluconate relea se d much more rapidly than expected for each of the sa mpl es. Th is may
be due to the majority of the ch lorhexidine being aro und the bandag e instea d of intercollated in between
the mat fibers. Becau se of this , the majority of the ch lorhexidi ne was released in the first two to three
days and, in the case of the standard bandage with no cross -lin king, the drug was almost ent irely eluted
from the bandage by day four (Figure 28). However, the mat /adhesive interact ion is evident in that not all
of the antimicrobia l was immediate ly relea sed into the so luble pha se. Because the ad hesive is aqueo us, it
is a re liab le assumpt ion that the drug remained "s tuck " in the nanofiber s through an adhesive /fibrous mat
interaction. These interact ions seemed to be increased with the add ition of glutara ldehyde as a cross42

linkin g age nt. In this case , a large burst of chlorhexidine release was seen as late as day three (Figure 28).
The glutarald ehyde also had a s light release after day five and up to day eight.

I. Cytotoxicity Evaluation
Rationale
Toxicity testing of the bandage was important to the project to demon strate the ability of SpiderSkin to
promote healin g without causing fu1ther damage to the epidennis. Any toxic materials which are able to
leach out of the bandage wou ld pose a threat to the healing ability of the wound . There are generally three
types of cytotoxicity tests that were ava ilable to choose from. First, the direct contact method involves
grow ing a culture of cells to confluen cy, placing the biomaterial on the surface and evaluating
cytotoxicity us ing live/dead cell counts. Second, agar diffusion works by minimizing the influence of
phys ical contact between cells and biomateria l. Agar is placed between the ce lls and the material and the
leachables from the biomater ial are allowed to travel through the agar. The final method is the elution
method. In thi s method the biomaterial is soaked in media, allowin g leachab les to trave l from the
biomaterial into the media. Thi s same med ia is then used to grow ce lls. Advantages an d disadvantages of
eac h of these meth ods are out lined in Figure 29.
Agar diffu sion

Eluti on

Eliminate extrac tion preparation
Zon e of diffusion
Better co ncentr ation gradient of
toxicant
Can test one side o f a mate rial
Independent of material density

Sepa rat e extraction from testing
Dose response effect
Extend expo sure time

Dir ect contact
Advantages

Eliminate ext raction prepa ration
Zone of diffu sion
Ta rget cell con tact with material
Mimic physiological conditions
Standar diz e amou n t of test materia l or test
ind eter minate shapes
Ca n exten d expos ure t ime h y adding fresh
media

Disadvantages

Cellular tra uma if mate rial moves
Cellular trauma with high density mater ials
Decreased cell population w ith high ly soluble roxicants

Choice of ext ract conditions
Choice of solvents

Use filter paper disk to test liq·
uids or ext racts
Requ ires flat su rface
Solubil ity o f toxicant in agar
Risk of th ermal shock w hen pre·
pa ring agar overlay
Limited exposure time
Risk of absorbing wate r from

Addit iona l time and steps

aga r

Figure 29. Description and Com pari son of Cytotoxicity Testing Methods.
Decisions
The method chosen was most similar to the elution method. Thi s method was decided upon because it
was a quick and simple meth od to determine the cytotoxicity of leachable chemicals from the bandaging
material. Other poss ible methods could have included animal testing models , sample submer sion cell
culture , or chemi ca l testing of leachab les into solution. Th e animal testing model was decided against due
to the complexity of testing and the high varia bility and interferin g var iables. Sample subm ers ion cell
cultur e was dec ided against due to lack of materials and the added co mplexity of the test ing mode l.
Chemical test ing of leac hab les into so lution was not used because it wou ld be diffi cu lt to tie thes e results
to cytotoxic ity in vivo. MRC-5 ce lls were used beca use they are commonly used in cytotox icity studies
and could be obta ined from GE Healthcare Hyc lone. The design decision tree can be seen in Figure 30.
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Test all bandage
compositions for
cytotoxiclty

Testing Materials

Testing Method

Determine
requirements of
testing design

Direct Contact

Determine capacity
to perform testing
design

Agar Diffusion

Elution

Capicity to perform
test

Cell Une {MRC-5,
Vero)

-W

Media {HyColne
Provided)

Container(Flask,24
well plate)

Figure 30. Decision tree for cytoto xicity evaluation.
Materials

•
•
•
•
•
•
•

8 mL screw cap tubes with a flat base
Nunc lon 24 we ll plate s
MRC-5 Lung ce lls
DMEM + I0¾FBS media
50% glu taraldehyde in solution
Trypsin
ViCell

I 0% Ny lon + 10% rMaSp I dope:
•

3 mL Formic Acid 97%

•

0.3 g Nylon (Rio 20# Monofilament)

•

0.3 g rM aSpl

12% 50/ 50 rM aSp l/ rMaSp2 rSSps ad hesive:
•

3 mL distilled water

•

0.18grMaSp1

•

0.18grMaSp2

•

0.03 µI G lutara ldehyde (50% stock so lution)
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o

Bovine Serum Albumin (BSA)

12% 50/ 50 rMaSpl /rMaSp2 + 1% Glutaraldehyde rSSps adhesive:
•

l mL 12% 50/ 50 rMaSpl/rMaSp2 rSSps adhesive

•

20 µI 50% glutaraldehyde stock

Methods
The desired amount of electrospun mat/rSSps adhesive was weighed out using an analytical scale
(weights within the range of l 0-30 mg). Weighed out mats were placed in petri dishes and exposed to UV
light in a sterile hood for 20 minutes on each side. Sterilized mat was then added to 5 mL of DMEM +
l 0% FBS media in 8 mL tubes. The tubes were then allowed to shake in an incubator for 20-24 hours,
allowing the mats to leach into the media. The 8 mL tube s were then placed under a sterile hood and the
mat material was removed using tweezers. The media was then run through a 22 um syringe filter to
remove any mat pa1ticulate remaining in the med ia. 4 mL of each media treatme nt was then placed in a
new 8 mL tube , and the remainder was discarded. The amo unt of inoculum required to get l 0,000
cells/cm 2 was then calculated, and each of the 8 mL tube s was inoculated with the same volume of
inoculum. 1 mL of this inoculated media was then placed in the 4 wells of a column of a 24 well plate.
The plate was covered and placed in an incubator . Fresh media , which had not been exposed to any mat
sample, was used as the negative control , while a concentration range of 50% glutaraldehyde was used as
the positive control. The desired volume of glutaraldehyde was added to separate wells in the 24 well
plate.
To measure the cell growth of each media treatment , the cells were pulled into suspension using standard
adherent cell passaging techniques . 300 µL of trypsin was used and once the cells had released 600 ~LL
DMEM + 10% FBS was added. The cell densities were then determined on the ViCell Cell Counter.

Results
Initial Trial:
The initial trial was conducted with the mats and concentrations expressed in Table 4. Each tube was
inoculated at 5000 cells /cm 2 . As can be observed from Figure 31 there was a significant change in
coloration of the media during the 24-hour incubation period. This phenomenon was likely due to
contamination of the mats when they were immersed in the media. Samples were eventually discarded
due to lack of cell growth and contamination issues.
Table 4. Initial Trial Cytotoxicity media treatments

Media Treatment

\ Concentration

Fresh Media (No Treatment)

NIA

Mat with SS + Glut. adhesive

10 mg
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Mat with SS + Glut. adhesive

20 mg

Mat with SS + G lut. adhesive

30 mg

Mat with SS adhesive

10 mg

Mat with SS adhes ive

20 mg

Mat with SS adhesive

30 mg

SS Mat with No Adhesive

40 mg

50% Glutaraldehyde solution

10, 20, 30, 40, 100, 200, 300, and 400 ul

(A)

(B)

(C)

(D)

Figure 31. Cytotoxicity testing . (A) media samples with treatment before incubation (B and C) media
samp les after 24-hour incubation. (D) 24-we ll plates wit h post-incubation media.
UV Trial 1:
The initial trial was cond ucted with the mats and concentrations expressed in Table 5. Vials were
inoculated at 10,000 cel ls/cm"'2. Prior to immersion in the media , each mat sample was sterilized using
UV radiatio n as can be seen in Figure 32. Ce ll counts were taken on day 5 after inoculation and results
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can be see n in Fig ure 33. It was observed that viable cell density read ings were outside the recommended
range of the Vi Ce ll cell counte r.
Table 5. UV trial 1 cytotoxicity media treatments
Media Treatment

Concentratio n

Fres h Media (No Treatment)

NIA

Mat with SS + Glut. adhes ive

10mg

Mat with SS + Glut. adhesive

30 mg

Mat with SS adhesive

10 mg

Mat with SS adhesive

30 mg

50% Glutaraldeh yde so lution

5, 10, 15, and 20 ul

Figu re 32. UV techniques and setup for sample steri lization

(A)

(B)

Figure 33. Cytotoxicity testing. (A) media samp les w ith treatment before incubation (B) media samp les
wit h treatment after 24-hour incubation.
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UV Trial 2:
The initial trial was conducted with the mat formulations and concentrations expressed in Table 6. Via ls
were inoculated at 10,000 cells/cm2 • Prior to immersion in the media, each mat sample was sterilized
using UV radiation. After inoculation, the media was extruded through a 22 um syringe filter to remove
mat particulate matter. As can be observed in Figure 34 there was once again some discoloration of the
media indicating contamination during the incubation period . Cell counts were taken on day 6 after
inoculati on and results can be seen in Figure 35.
Table 6. UV trial 2 cytotoxicity media treatments
i

Media Treatment

Concentration

Fresh Media (No Treatment)

NIA

Mat with SS + Glut. adhesive

10 mg

Mat with SS + Glut. adhesive

20 mg

Mat with SS + Glut. adhesive

30 mg

Mat with SS adhesive

10 mg

Mat with SS adhesive

20 mg

SS Mat with No Adhesive

30 mg

50% Glutaraldehyde so lution

I, 2, 3, and 4 ul

(A)

i

;

(B)

Figure 34. Cytotoxicity testing. (A) media samp les with treatment before incubation (B) media sample s
with treatment after 24-hour incubation.
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Figure 35. Average Viable Cell Density under various treatments. Error bar s constructed us ing one
standard error from the mean.

Conclusion
The purpose of these tests was to determine the plausibility of using these electrospun
mat/adhesive formu lations as bandages . Bandages which leach cytotoxic by-products would not meet the
overall design criteria of creating a non-cytotoxic bandage. As can be observed in Figure 35; all
SpiderSkin bandages including glutara ldehyde had s ignificantl y lower viab ility . Due to these results, there
will need to be caution and fu1ther research done for the glutaraldehyde treated bandage s. However, it is
important to note some of the testing parameters in reference to these results. MRC-5 is a notoriously
difficult cell line to work with. It would make the results stronger to have more replications of each
condition grown in larger volumes. This wou ld ensure that a lack of growth was in fact due to bandage
propertie s and not bad growth populations. That being said, it does appear very clear from the data
obtained that glutaraldehyde -leaching caused cytotoxicity (seen in Table 7). It has been shown in the
literature (Bhamidipati, Coselli, & LeMaire, 2012) that glutaraldehyde can be used for indwelling medical
devices without causing a cytotoxic response. These applicati ons are made possible when the
glutaraldehyde cross-links completely and there is no excess glutaraldehyde to cross link with unintended
tissues . This excess glutaraldehyde was likely the cause for the cytotoxic response see n in the SpiderSkin
bandage material. It would be beneficial to do more testing on the required concentrations of
glutaraldehyde needed to ensure complete cross-linking, without compromis ing the biocompatibility of
the bandaging material.
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Table 7. Score chart for cytotoxicity assay

Score ( 1-5 based on ce ll growth)

rSSps + Glutera ldehyde
adhesive/rSSps + Nylon Mat

rSSps adhes ive/rSSps+Ny lon
Mat

I

5
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Final Design Review
The deci sion prog ress ion throu gho ut thi s design process can be seen in Figure 36. Th e areas highli ghted
in blue show the paths followed that led to the final product, SpiderSkin. While there are st ill many areas
left to be explored in the de sign of an interactive and tunable banda ging system, th e fin al produ ct of this
proj ect serve s as a prot otype.
T-

SpiderSkin

Figure 36. F inal flow diagram. Aspects incorporate d into the final design have blue fill.
The final formulation of the mat and adhesive for SpiderSkin was chosen to be the Nylon/rMaSpl and
12% 50/ 50 rMaSp 1/rMaSp2, res pectiv ely. This formulation resulted in similar mechanical propertie s to
the Nylon /rMaSp 1 and 12% 50/ 50 rMaSp 1/rMaSp2 + 1% Glutaraldehyde for mulation , howeve r in
cyt otoxici ty testing glutaraldehyde at 1% concentra tion was causing cyto toxicity. Without sacr ificing
mechani ca l stability , the chosen fonnulation maintain s biocompatibilit y with mammali an cells.

In mech anical prop e11ies, the chose n formulation, deemed "S piderSkin ," is more comparable to skin than
to Tegaderm or wate r-proof Band-Aid. While providing protecti on similar to these commercial products,
the product is a lso able to provide supp o11similar to that of skin for large r epith elial injurie s.
As was expected from the biocomp at ibility propertie s of spider silk, SpiderSkin does not decrease the
viability of ce lls. Thi s leaves room for fu11her exploration of the poss ibiliti es of SpiderSkin as a cell
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scaffold. Antimicrobial incorporation into the adhesive produced a strong initial bur st of chlorhexidine,
however the relea se was not sustained over a desired period of seve n to ten days.
The initial goals of this project were to create a bandaging product that could compete with existing
bandaging product s, and add more factors to promot e wound healing. Although most of the objectives
were achieved, the ones that were not have been noted for future work. Figure 3 7 shows the simplified
design process, while Table 8 illustrate s the initial objectives compared to the results that this design was
able to achieve.

ElectrospunMat
TensileTesting

SpiderSkin
rSSpsAdhesive

Antimicrobial
Release

Figure 37. Overview of the design process for the final product.
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Table 8. Comparison between initial objectives and final results.
Initial Objectives

Results Achieved

Use glutaraldehyde as a cross-linking agent to
strengthen the mechanical properties of the
adhesive.

In some cases, glutaraldehyde offered
statistically significant increases in mechanical
properties under different environmental
conditions. However, these increases were not
drastic.

Create a mat /adhesive complex with and
without cross-linking that stretches without
removal in cyclic flexion and compression on
pigskin.

Under cyclic compression the rSSps and rSSps

+ glutaraldehyde samples produced similar
results to the Tegaderm and Band -Aid
controls, with minimal from the pigskin.
Under cyclic flexion, the rSSps and rSSps +
glutaraldehyde samples had similar results to
the Band-Aid samples, and outperformed the
Tegaderm samples .
The SpiderSkin adherence was not affected by
wetness and humidity compared to the
controls.

Ensure that the bandage does not exibit
cytotoxicity, with paticurlar focus
glutaraldehyde treated bandages.

Excess glutaraldehyde that was not crosslinked in the SpiderSkin bandage was shown to
be cytotoxic.
The SpiderSkin bandage without
glutaraldehyde did not exhibit any cytotoxicity.

Create an rSSps antimicrobial adhesive using
chlorhexidine and exhibit a release of the drug
over time .

A release profile of chlorhexidine was created
from the rSSps and rSSPs + glutaraldehyde
adhesives. The adhesive with the
glutaraldehyde showed a slightly longer release
profile, and a secondary peak around day
three.

Design a mat /a dhesive complex that adheres to
the skin as well as or better than conventional
skin adhesives.

SpiderSkin showed ability to maintain more
adherence under dry wet and humid conditions
when compared to Tegaderm and Band-Aid
controls.
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Discussion
Selection of Mat/rSSps Adhesive
By doing a criteria comparison test using the criteria: ease of spinning, material availability , and the
pressure sensitive tape test results it was possible to obtain an rSSps adhesive /mat formulation that would
work well for this design process . Using these criteria as guidelines helped create a product that would be
easy to work with as well as easy to test. Of course , in the future much more research can be done on
altering these formulations to achieve a wide variety of mechanical prope1ties depending on the desired
application /area of the body that bandaging material is needed. Nylon was not the ideal polymer to blend
with the rSSps to make the final electrospun mat mostly due to the fact that it is not biodegradable.
However , other polymers proved to be too hard to spin and combine with the rSSps in order to complete
their testing. Without fu1ther investigation into the electrospinning methods using these polymers , it is not
possible to tell whether nylon was the ideal choice for this product. However, adequate mechanical
properties were achieved using nylon and the design objectives were met.

T-Peel Testing
Using the T-Peel testing method was the best way to quantify the adhesive properties of the SpiderSkin
product. This testing method is commonly used for tissue adherence testing and allowed for a quantitative
evaluation. The SpiderSkin adhesive without glutaraldehyde did not exhibit a decreased adherence when
exposed to different environmental conditions like moisture and complete submersion. Although this
adherence did not quite match the adherence of the water-proof Band-Aids , it did outperform Tegaderm
in every environmental condition. Ft11the1more,the cross-linked rSSps adhesives exhibited a stronger
adherence to pigskin than their counterparts especially in the dry and wet testing categories. With these
results, it is reasonable to conclude that the cross-linking did allow for the adhesive to bond more strongly
with the skin tissue. This finding was statistically significant, however it was not as drastic of a change as
was expected. This could be due to the fact that the concentration of glutaraldehyde to optimize crosslinking was not studied. There may be a better method to include this component to obtain the best
mechanical properties possible.

Cyclic Fatigue Testing with Bandages in Compression
Cyclic fatigue testing was a valuable parameter for the quantification of the durability of SpiderSkin. As
bandages are constantly being subjected to compression /extension, cyclic testing is a necessity in
evaluating the viability of the product in real-world application. SpiderSkin matched the compression
durability of Tegaderm and Band-Aid, and exceeded the result of Band-Aid under wet conditions.
As SpiderSkin, Tegaderm , and Band-Aid all yielded high results, fwther testing should be conducted to
evaluate the bandaging systems under a greater number of cyclic compressions. In this testing ,
glutaraldehyde did not seem to exhibit a significant impact on the durability of the product , although that
impact may be observed under more extreme cyclic testing.
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Cyclic Fatigue Testing with Bandages in Flexion
Similar to cyclic testing in compression, cyclic flexion testing is valuable for quantifying the durability of
the SpiderSkin. An inability to flex with the needs of the patient could cause the bandage to come off
prematurely, increase pain , or aggravate the wound in its recovery stages. More variability was seen in
tlexion than compression, and SpiderSkin yielded higher results than commercial products in almost
every condition.
Inflexion testing, glutaraldehyde seemed to decrease the durability of the bandage. This is likely due to
an increased number of crosslinked proteins , inhibiting the ability of the bandage to stretch with the skin.
Band-Aid s were most able to compete with SpiderSkin, and Tegad erm was the least durable. In summary,
SpiderSkin matched or exceeded the durability of its commercial counterpa1ts in every condition.

Tensile Testing of Materials
Tensile testing is a valuable metric for describing the mechanical prope1ties of the bandage itself. As
previous T-Peel and fatigue tests are valuable for comparing the adhesive propertie s of the bandage ,
tensile testing describes the entire bandaging system, encompassing both the mat and adhesive. Individual
parameters will be discusse d in their respective spheres, followed by an integrative discu ssion of the
prope1tie s and their implications to the product as a whole.

Toughness
SpiderSkin was considerably less tough than Tegaderm and Band-Aid. This phenomenon will be
explained further in subsequent parameters obtained via tensile tests, however , the lower resultant values
for toughnes s are due to the rigidity of the SpiderSkin bandage relative to the elastic natures of both
Tegaderm and Band-Aid.

Elastic Modulus
SpiderSkin had a much higher elastic modulu s than Tegaderm and Band-Aid. Higher values of elastic
moduli indicate that greater pressure must be exe1ted before defonnation in the product will occur. As
was expected , the d1y condition resulted in higher elastic moduli than in wet/humid condition s, as water
permeating the bandage allows the bandage to relax and become more elastic.
SpiderSkin more closely mimicked the elastic modulu s of human skin than did either commercial
product. This can be advantageous as the body seeks to repair the wound. Beyond providing protection
for the wound, spidersilk can give suppo11 similar to that of skin. As underlying repair mechanisms and
newly formed ti ssue are ve1y delicate and sensitive to mechanical perturbations , the relative inelasticity of
SpiderSkin can prevent excessive stress from disturbing sensitive tis sue.

Strain
Tegaderm and Band-Aid were much more elastic than SpiderSkin. Although a higher elasticity would be
preferable if the elastic modulu s and were able to be maintained , SpiderSkin resulted in similar/higher
values of strain as compared to human skin. Whereas Tegaderm and Band-Aid stretch to many times their
original size, Spiderskin averaged about 1.5 times its original length .
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Ultimate Tensile Strength
As is often correlated with a higher modulu s of elasticity, SpiderSkin resulted in higher ultimate tensile
strength values than did Tegaderm or Band-Aid. As was discussed previously, this can be advantageous
for providing support to und erlying tissue as it is very sens itive during the repair proce ss. Once again,
SpiderSkin more closely mimicked the properties of human sk in as compared to the commercial products
Tegaderm and Band-Aid.

Integrative Discussion
Spiderskin has favorable mechanical prope11ies for use in severe epithelial injury. While providing needed
protection , having similar stre ngth and elasticity allows the bandage to provide suppo11 beyond what
commercial products provide. Thus, instead of mechanical stresses being applied to delicate tissue, the
perturbations will be dispersed along the bandage and app lied to healthy surrounding tissue.

Chlorhexidine Release
The ability of this bandaging product to be functional and promote healing is integral to the design
product and it creates the possibility to set this product apa11from other products on the market. Using
chlorhexidine in the rSSp s adhesive instead of incorporating it into the electrospun mat fibers was not
ideal, howe ver with further research it is proposed that this would be plausible in the future by altering the
concentration of chlorhexidine in the electrospinning dope. Without this antimicrobial in the fibers, a
longer and susta ined release was not expected, however in this sce nario it was possib le to test the physical
entanglement interaction between the rSSps adhesive and the electrospun mat nanofibers. Because the
rSSps is aqueous, much of it was expec ted to release early, however the addition of glutaraldhyde allowed
for more chlorehexidine gluconate to stay in the bandage upon submers ion. This is evident by the high
amount of mass released as late as day 3 (Figure 29). This level of mass release is comparable to the same
amount that was released almost immediately upon submers ion from the standard bandage. Even without
the gluataraldehyde, how ever, it is evident that the physical entanglement of the rSSps adhesive /fibrou s
mat complex can hold in at least some of the antimicrobial. As you can see in Figure 28, even the
stan dard bandage had a slight release of antimicrobial as late as day 4 submerged in phosphate-buffered
saline. With these result s in mind, it has to be noted that it would be rare in real-life application for this
"second skin" material to be fully submerged for long amounts of time. Therefore, these results represent
the fastest release possible. It is probabl y that the release may be more sustain ed over longer periods of
time in conditions that have varying levels of moisture. For fu11her research , it may be most beneficial to
create this product with an antimicrobial both in the rSSps adhesive and in the fibers of the electrospun
mat. Of course, the different concentrations of antimicrobial in the complex may need to be tuned for
optimal effectiveness.

Cytotoxicity testing
The biocompatibility of the bandage is significant as it will be applied to compromised tissue. The focus
of the cytotoxicity tests was to determine initial toxicity of spider si lk banda ge with spider silk based
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adhesive and the effect of the addition of the cross-linking agent glutaraldehyde. The tests showed that the
addition of glutaraldehyde to the adhesive did cause cytotoxicity. It is hypothesized that this was due to
excess glutaraldehyde in our adhesive formulation which was not crosslinked. This non-crosslinked
glutaraldehyde was free to interact with the cells and cause cell death or inhibit cell growth. Due to this
finding, our final design product will be created without the addition of glutaraldehyde. The mechanical
properties of the rssp's adhesive were satisfiability close to those of skin to accomplish our initial design
criteria without the need for a crosslinking agent. It was, however, observed that the addition of the
glutaraldehyde adhesive improved the release profile for chlorohexidine. It is recommended that further
studies be done to determine the correct concentration of glutaraldehyde which will prevent cytotoxicity
but still allow for crosslinking benefits. It has been shown in the literature (Bhamidipati, Coselli , &
LeMaire, 2012) that glutaraldehyde can be used for indwelling medical devices without causing a
cytotoxic response . Cell adherence studies would also be wo1thwhile to show bandage benefit to tissue
regrowth.
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Conclusions
Through an intensive design process , a prototype of the final product has been created. The final
bandaging system ha s been ca lled SpiderSkin.
Tensile testing results showed that SpiderSkin has mechanical properties more similar to human skin than
commercial bandaging products such as Tegaderm Tape and water-pro of Band-Aids. Further mechanical
testing of the adhesive showed the ability of the adhesive (compared to the Tegaderm and Band-Aid
controls) to stay on the skin as it underwent cyclic fatigue under wet, humid and dry conditions. Thus ,
while providing superficial protection sim ilar to a bandage , SpiderSk in can also provide mechanical
suppo1t to injuries in variab le conditions. Fu1thermore , SpiderSkin has the potential to be loaded with
antim icrobial s and/or growth factors to fu1ther protect a wound and encoura ge healing.
Although the de sign objectives were achieved within the scope of this project, this design was only able
to cover the initial investigation into an exciting new product. Further research shou ld be considered to
continue impro v ing the SpiderSkin bandaging syste m. The following is a list of potential branches for
fu1ther research and these areas are detailed in the next section:
•
•
•
•
•

The co ncentration of glutara ldehyde and other cross-linking investigations shou ld be studied to
prevent cytotoxicity
Incorporate antimicrobial into electrosp un mat nanofiber s to prolong the antimicrobial release
Incorporation of growt h factors
Comb inati on of rSSps with other biodegradable polymers to impro ve mechanical properties
Testing of cell adhesion to electrospun mat as potential app lication for a cell scaffo ld

Recommendations for Future Work
Alternate Polymers/Mat Formulations
Due to the time constraints of this project, it was not possible to explore all of the different polymer/mat
formulations that could be used to create this bandaging product. Nylon was the main polymer chosen for
testing due to its availability to us and the previous research on electrospinning with recombinant spide r
silk that had already been done with nylon. However , we believe that using a degradable polymer may be
best for spec ific applications. The use of alternate polymers would require much more research on their
use in electrospinning and how they may integrate with recombinant spider silk proteins. Fo1tunately,
much research is currently being done on the production of biodegradable polymers , both synt heti c and
natural. Possible choices of synthetic biodegradable polymers include starch -ba sed polymer blends and
polylactic acid blends , wh ile natural biodegradable polymers includ e cellulose and soy proteins.
Furthermore, it may be possible to create a product made of on ly recombinant spider silk protein , since
this can be tuned for degradability, however pure spider si lk is hard to electrospin and more research
would need to be done to produce a purely rSSps electrospun mat. Films , foams , and ge ls made of
recombinant spider silk protein may turn out to be better for some of the bandaging and drug delivery
applications as well.
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Alternate Antimicrobial Constituents
Chlorhexidine was the antimicrobial chosen due to recommendations from health care professionals and
biomedical companies. Antibiotics are not a good choice for this product because of the high risk of super
bugs and antibiotic resistant infections occurring. However , electrospinning using zinc oxide
nanoparticles or silver may be good alternatives to an antimicrobial like chlorhexidine. From the results
we obtained , it seems that to have a sustained release of an antimicrobial, it would be best if the fibers
themselves contained the antimicrobial constituent within them, instead of trying to incorporate the
antimicrobial within the adhesive. Again , this would depend on the desired application /type of injury.

Cell Attachment / Capability as a Scaffold for Epidermal Recovery
Preliminary research has shown that rSSps materials have potential for cell scaffolding and cell
attachment. With fu11her research, it may be possible to incorporate epithelial cells onto the surface of the
fibrous bandage. This would allow for a porous , integrative structure for cell growth and attachment. As
this is applied to the skin, it may be possible to encourage epidermal recovery.

Cross-linking
In this study , glutaraldehyde was used as the cross-linking agent due to the fact that it is commonly used
as a tissue cross-linking agent. However , excess glutaraldehyde is a proven cytotoxin. Further research
needs to be done to deactivate the remaining uncross-linked glutaraldehyde or to find the exact
glutaraldehyde concentration needed to maximize cross-linking , while having very little excess at the end
of the process causing toxicity.
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Timetable
Identify the problem

To create a spider silkbandage to
~ used in conjunction with a
spray on adhesive, for the
treatment of pressure wounds

Gather information

Research existing bandage types and
the problems they can aiu .se

3 months

Re.sHrch properties of each type of
biomaterial to be used

Develop possible
solutions

Analyze and select a
solution

Brain storm and test ideas for
concentration of spider silk and
additives, such as antimicrobials

3 months

Comparesolutionsto criteriaand
evaluateto choosethe bestones

lmonth

Test solutionsandchangeas

4months

Test and evaluate the

needed

solution

Finalize project

Finalize details
Make posterand presentation

1 month

Figure 38. Timetable for completion of this project.

Background, Literature Review, Project Aims and Objectives
Personnel: All members
Completed: March 2016

Pressure-sen sitive Tape Test
Personnel: Ana Laura Licon , Danielle Gaztambide
Completed: May 19, 2016
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SEM Imaging of Electrospun Mat/ Adhesive Formulations
Personnel: Danielle Gaztambide, Ana Laura Licon, Thomas Harris
Completed: May 2016

T-Peel Adhesion Test On Pigskin
Personnel: Danielle Gaztambide, Ana Laura Licon, Sam Briggs
Completed: Trial I-May 2016 and Trial 2-July 2016

Electrospun Mat/ Adhesive Tensile Testing
Personnel: Danielle Gaztambide, Sam Briggs, Ana Laura Licon
Completed: July 2016

Fatigue Testing On Pigskin and Analysis
Personnel: Danielle Gaztambide, Ana Laura Licon, Michael Paskett
Completed: End of July 2016

Chlorhexidine Elution and Analysis
Personnel: Danielle Gaztambide, Thomas Harris
Completed: November 2016

Cyclic Stretching Test on Pigskin
Personnel: Danielle Gaztambide , Ana Laura Licon
Completed: October 2016

Analysis of Tensile Testing Data and Statistical Analysis
Personnel: Michael Paskett
Completed: October 2016
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Analysis ofT-Pee l Data
Personne l: Ana Laura L icon, Michael Paskett
Com pleted: Octo ber 20 16

Toxicity Testing
Personnel: Sam Briggs, Ana Laura Licon, and Danielle Gaztambide
Complete d: October 20 16

Analysis of Tox icity Testing
Personnel: Sam Briggs
Comp leted: October 2016

Statistical Analysis on a ll Other Tests
Perso nne l: Mich ael Paskett
Completed: October 2016

Write-Up and Fina l Repo1i/Poster
Personnel: Sam Briggs , Danielle Gaztamb ide, Ana Laura Licon, and Mic hael Paskett
Complet ed: December 2016
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Reflective Writing
For my senior capstone project , I have been working in Dr . Randy Lewi s Spider Silk Laboratory,
designing a "seco nd skin" from recombinant spider silk protein s. With a group of four undergraduate s we
have worked this project from conceptualization stag es to a final product. Through this project, I have
learned about the complete spectrum of research and design. It has been a valuable project and the related
experience will benefit me greatly as I pursue graduate education.
Our project began with a brain storm. As our group was working in the Spider Silk Laboratory, we
had many potential applications to choose from . After hearing the experience of a postdoc toral fellow at a
conference, we realized that there is a big market for bed sore/bum victims. We started to hypothesi ze
different method s of formulating our bandage and adhesive, and drew up a proposal which was later
approved by the department.
We produced several formulations for the mat for our bandage and performed mechanical testing
on the mat to ensure we had the prope1ties we needed in a bandage. After making a decision on which
formulation of mat to use in the final product , we moved on to adhesive formulations.
Similar to choosing a mat formulation, we tested out severa l spider silk adhesives to use with our
mat. We performed several tests on the adhesive in combination with the chosen mat. We harv ested pig
skin, and te sted the formulation's adhesion to pig skin. Pig skin gave us a good representation of how the
product would perform in vivo.
After the selection of a mat and adhesive, we began testing an antimicrobial compound,
chlorhexidine , and its ability to prevent bacterial growth when incorp orated into the bandage. Through
our testing we found that there was no growth, however the inhibition was likely due to our antimicrobial
and an additive in the adhesive. Finally, we evaluated our product's biocompatibility by growing
mammalian cells in the presence of our bandage .
Overall, my experience in the spider silk laboratory has been very good. I have been able to learn much
more about the research process. I have been able to interact with very intelligent people who have given
me great advice for pursuing my goals in both the academic and professional world. I have been exposed
to many different thinking and working styles and those have influenced my own personal sty les of work
and thinking.
My experience with this senior capstone project will benefit me greatly. I have gained a much deeper
foundation for the research process. I have learned better how to work with groups and manage dates and
deadline s. As I am soon to begin research in a graduate setting , my background from the capstone project
adds a major experience component that will be unlike many peer s.
My time in Dr. Lewi s' Spider Silk Lab has been a great experience for multiple reasons. I have been able
to understand and apply practical information about proteins and purification better. As I have increased
my scientific understanding of what goes on in the laboratory , I have also become more familiar with the
managerial aspects of laboratory work. I am excited to continue my work in the laboratory.
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As a mentor , Dr. Lewis has been very help fu l. He has been hands-off, allowing us to perform the resea rch
in o ur ow n way, while providing va luab le input and feedback whenever we need it. Our relationship is
very similar to wha t I wi ll look for in a grad uate sett ing as we ll. I couldn't really say that there were any
d iffic u Ities.

Lastly, I wa nt to share some advice I have for future capstone proje cts:

1.

Realize the impo1tance of yo ur team.

2.

Don't bite off more than yo u ca n chew .

3.

Utilize resources within and without the laboratory.

1. Your team w ill (hopefully) become your best fr iends for the duration of the project. Yo u wi ll spend
more time thinking abo ut your project and wo rking on that than you want to. The impo1tance of tru st and
hard work from all membe rs is critical to your success . I was lucky to have honest, hard-w orking
teammates who didn't put off any work that needed done. With that trust for eac h other, we were ab le to
co mplet e a large amo unt of testing in a relatively shmt amount of time . It is more imp o1tant to like yo ur
team than the research you wi ll be condu cting. Research, by nature and of necessity, can be repetiti ve and
get boring. Th ere will be times when none of you want to pe1form testing , data ana lys is, literaturesearc hes, writin g, and th e wide array ofresponsi bil ities with taking on a senior project. If you and your
team get along we ll, people won' t be shirkin g duties out of laziness. It is impo1tant to have a team with a
variety of sk ills. Although we had all worke d in the same lab, eac h membe r brought specific skillsets and
kno w ledge that were absolutely neces sary to comp leting a project from such diverse concepts. In
summary, don't choose a project and then a team. Choose a team and then a project. Reversing the
chronology of these events can cau se problems down the road.
2. I don' t know exactly what other maj ors are like, but for Biological Enginee ring we had about 3
semesters to formu late, carry out, and repo1t on a project. It seems like a lot of tim e. We had a lot of
ideas. That time proved to be far insuffic ient for the number of ideas we had. Realize that on top of your
proj ect, yo u are st ill going to have class, homewo rk, work, and (if yo u really budget yo ur time) some
form of a socia l life. Decide ear ly what the fundamental needs are for your project and finish those. If you
have any extra tim e, pursue some of the addi tion al ideas yo ur tea m has had along the way. Don ' t get
distracted along the way and forget about your fundamental requir ements. We had lots of ideas. Some of
which we began to pursue before it was ap propri ate. Don ' t make the same mistake we did. It' s very easy
to ove rlook the additi ona l work beyond the pursuit of the ideas . We didn ' t think abo ut finding more
literatur e, analyzing data , and writing when we began to pursue some of our little ideas .
3. Think criticall y about the resources yo u have and use them . You are sti ll a student. This is a learn ing
proj ect. Yo u are n't expected to begin as an expe 1t on every method yo u encou nter. You probab ly don't
even know some of the methods exist which cou ld be very beneficial to eva luatin g your product. You
have graduate students as an easy resource. If they don' t know , reach out to post-doctoral resear chers.
Your principal investigator will know if they don't. If within yo ur lab you don't have enough of those
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resources, look to other labs. The research community is a pretty friendly one. Don ' t be afraid to reach
out to another profes sor's lab. If you read a paper and want some more information about it, contact the
author. You' II be surprised how nice people actua lly are, even if they don ' t know you.
I hope this helps some of you on your endeavor. Senior design projects are a lot of work, but it's
experience that can really he lp you to stand out as a student if you do it the right way. Good luck!
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Appendix A: Mat Formulations
Electrospun mats were used as the base for the scaffold complex made. Three different initial mat
formulations tested: 20% nylon , 10% nylon 10% rMaSpl, and 10% nylon 10% 80/20 rMaSpl /rMaSp2 ,
all of which were disso lved in formic acid. To make the 20% nylon solution 0.6 g of nylon were placed in
a glass vial with 3 .04 mL of 97% formic acid. To make the nylon rMaSp l/rMaSp2 so lution 0.3 g of
nylon, 0.24 g rMaSpl and 0.06 g of rMaSp2 were added to a glass vial with 3.04 mL of97% formic acid.
To make the nylon rMaSpl mats 0.3 g of nylon and 0.3 g of were added to a glass vial with 3.04 mL of
97% formic acid. As each solution was made, it was left on an end-over-end plate mixer plate overnight
for the and nylon to dissolve into a homogenou s solution.
Each polymer solution was placed into 1 mL syringes fitted with a 0.5 inch 27-gauge flat tip disposable
needle . To make a mat a needle filled with one of the solution s was placed into the electrospinner. The
electrospinner was set to an extrusion rate between 0.25-0.3 mL/h and the voltage kept between 24-29
kV. The drum was wrapped with a sheet of nonstick aluminum foil and set to rotate at 1000 rpm. The
positive wire on the electrospinner was attached to the syringe and the rotating drum was connected to the
negative wire. Each mat was spun for about 3.5 hours until the solution in the syringe had been used, and
a compl ete mat had been formed.
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Appendix B: Adhesive Formulations
Three different adhesives were initiall y tested on the electrospun mats: a 12% 50/50 rMaSp l/rMaSp2
adhesive , a 12% 50/ 50 rMaSp l/rMaSp2 with 1% glutaraldehyde, and a 12% 50/50 rMaSp I/rMaSp2 with
I 0% bovine serum albumin (BSA) and 1% glutaraldehyde.
To make the 12% 50/ 50 rMaSpl /rMaSp2 adhesive 0.18 g ofrMaSpl and 0.18 g ofrMaSp2, and 3 mL of
distilled water were added to a small glass vial with a screw on lid. A sonicator was used with a microtip
to create vibrations to break down the larger rSSp agglomerates , and increa se protein solubilization. The
vial was microwaved in 3-second interval s until it reached 250 °C and the protein was completely
di sso lved. The 12% 50/50 rMaSp 1/rMaSp2 with 1% glutaraldehyde was made in the same way as the
12% 50/ 50 rMaSp 1/rMaSp2 adhesive, but 0.02 mL of a 50% glutaraldehyde stock was added per I mL of
the rSSps adhesive to make it a l % glutaraldehyde solution. The 12% 50/50 rMaSpl / rMaSp2 with 10%
BSA and l % glutaraldehyde was mad e in the same way as the 12% 50/ 50 rMaSp l/rMaSp2 adhesive, with
an additional 0.02 mL of a 50% glutaraldehyde stock per mL of the rSSps adhesive and 0.3 g of BSA.
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Appendix C: Pigskin Cleaning
Pigskin was used to set the mat/adhesive formulation s for all of the tests except the toxicity assay. Strips
of fresh pigskin were acquired from the Utah State Univer sity South Farm. Hair clippers were used to
remove the bulk of the hair and then disposable razors were used to remove the final hair left after
clipping . The skin was washed in baths of 30% isopropyl alcohol and water, cut into smaller pieces,
sealed into bags, and kept in a 4°C refrigerator to keep the skin fresh for as long as possible
(approximately 3 week s). The skin was cut into smaller pieces as necessary for each test.
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Appendix D. Conditions Created for Mechanical Testing
Thre e different conditions were chosen for all of the mechani ca l testing: dry , wet, and humid . The dry
sa mple s were te sted as they were on the pigskin after the adhesive had dried . The wet sample s were
s ubmerged in water for 1 minute , dried with a paper towel and tested immediatel y . The humid samp les
were tested under 100% humidity conditions by using a humidifier attached to a plexiglass box with a
hose to saturate that space with water vapor. The humidity set up can be seen in Figure 39:

Figure 39. Setup for humidity testing
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Appendix E. Recombinant Spider Silk Proteins Used
All of the rSSp s used in this experiment were derived from the milk of transgenic goats. The sequences of
the two proteins used are shown below.
rMaSpl:

(QGAGAAAAAAGGAGQGGYGGLGGQGAGQGGYGGLGGQGAGQGA
GAAAAAAAGGAGQGGYGGLGSQGAGRGGQGAGAAAAAAGGAGQG
GYGGLGSQGAGRGGLGGQGAGAAAAAAAGGAGQGGYGGLGNQGA
GRGGQGAAAAAAGGAGQGGYGGLGSQGAGRGGLGGQGAGAAAAA
AGGAGQGGYGGLGGQGAGQGGYGGLGSQGAGRGGLGGQGAGAA
AAAAAGGAGQGGLGGQGAGQGAGASAAAAGGAGQGGYGGLGSQG
AGRGGEGAGAAAAAAGGAGQGGYGGLGGQGAGQGGYGGLGSQGA
GRGGLGGQGAGAAAAGGAGQGGLGGQGAGQGAGAAAAAAGGAG
QGGYGGLGSQGAGRGGLGGQGAGAVAAAAAGGAGQGGYGGLGSQ
GAGRGGQGAGAAAAAAGGAGQRGYGGLGNQGAGRGGLGGQGAG
AAAAAAAGGAGQGGYGGLGNQGAGRGGQGAAAAAGGAGQGGYG
GLGSQGAGRGGQGAGAAAAAAVGAGQEGIRGQGAGQGGYGGLGS
QGSGRGGLGGQGAGAAAAAAGGAGQGGLGGQGAGQGAGAAAAAA
GGVRQGGYGGLGSQGAGRGGQGAGAAAAAAGGAGQGGYGGLGG
QGVGRGGLGGQGAGAAAAGGAGQGGYGGVGSGASAASAAASRLSS
PQASSRLSSA
VSNLVATGPTNSAALSSTISNVVSQIGASNPGLSGCDVLI
QALLEVVSALIQILGSSSIGQVNYGSAGQATQIVGQSVYQALG)
rMaSp2:

(PGGYGPGQQGPGGYGPGQQGPSGPGSAAAAAAAAAAGPGGYGPGQQG
PGGYGPGQQGPGRYGPGQQGPSGPGSAAAAAAGSGQQGPGGYGPRQQG
PGGYGQGQQGPSGPGSAAAASAAASAESGQQGPGGYGPGQQGPGGYGP
GQQGPGGYGPGQQGPSGPGSAAAAAAAASGPGQQGPGGYGPGQQGPGG
YGPGQQGPSGPGSAAAAAAAASGPGQQGPGGYGPGQQGPGGYGPGQQG
LSGPGSAAAAAAAGPGQQGPGGYGPGQQGPSGPGSAAAAAAAAAGPGG
YGPGQQGPGGYGPGQQGPSGAGSAAAAAAAGPGQQGLGGYGPGQQGP
GGYGPGQQGPGGYGPGSASAAAAAAGPGQQGPGGYGPGQQGPSGPGSA
SAAAAAAAAGPGGYGPGQQGPGGYAPGQQGPSGPGSASAAAAAAAAGP
GGYGPGQQGPGGYAPGQQGPSGPGSAAAAAAAAAGPGGYGPAQQGPSG
PGIAASAASAGPGGYGPAQQGPAGYGPGSAVAASAGAGSAGYGPGSQAS
AAASRLASPDSGARVASAVSNLVSSGPTSSAALSSVISNAVSQIGASNPGL
SGCDVLIQALLEIVSACVTILSSSSIGQVNYGAASQF
AQVVGQSVLSAF)
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Appendix F. Understanding JMP® visual outputs
From the JMP® Tutorial:
Categorical plots:

25-,----------------------~
0

20 0

15

0

0

0

a

d
Drug

A black dot represents an individual datum point. In the green diamond , the center line represent s the
mean of the data. The top and bottom points represent upper and lower confidence points of each group.
The lines that slice the top and bottom of the diamond s are called overlap marks . If there is horizontal
separation between the top overlap of one group and the bottom overlap of another, the means of those
two groups could be significantly different. Group 'f appears to be different than group 'a' and 'd' in this
example.

Connecting Letters Report:
L.lConnecting letters Report
Level

f

Mean

A

d

B

a

B

16.285714
8.000000
7.142857

The letter table lists the group mean s with letters to the right of them. Mean s that have the same letter are
not significantly different. Tho se with different letters are different. Groups 'd' and a' are both denoted
with the letter 'B' -- they are not different. Group 'f has the letter 'A', different than both 'd' and 'a'.
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